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ABSTRACT 
BACKGROUND: The purpose of this study was to explore both positive screened MDD 
and the perception of being depressed (P) and the likelihood of either increasing if the 
patient suffered from arthritis (P/E), either perceived or evaluated by a physician.  The 
study explored the univariate, bivariate, and multivariate relationships between MDD and 
depression (P) to better describe influencing characteristics and their prevalence, as 
related to MDD and depression (P). 
METHODS: The study examined a cross section of patients 65 years and older (n=8,205) 
within the National Epidemiologic Survey on Alcohol Abuse and Alcoholism (NESARC) 
[2001-02] sponsored by the National Institute on Alcohol Abuse and Alcoholism 
(NIAAA).  A multivariate analysis was conducted using SAS Callable SUDAAN to 
account for the complex design of the study and adjusted odds ratios (ORs) of modeling 
were computed to account for Models 1-4. 
RESULTS: Those persons age 65 and older who report having arthritis (P/E) were 
significantly more likely to be suffering from MDD than those who have not reported 
having an arthritic condition (P/E) [results were positive within Models 2-4].  Those 
persons age 65 and older who report having arthritis (P/E) were not significantly more 
likely to be suffering from depression (P) than those who have not reported having an 
arthritic condition (P/E) [results were negative within Models 2-4].    
This creates significant concern, given that each of the multivariate models (2-4) 
examined arthritis (P/E) while utilizing the same control variables throughout.   Further, 
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many of the relationally significant variables in the MDD versus depression (P) models 
were not the same (Table 4.4 /4.5). 
CONCLUSION: This study demonstrated a significant difference within the senior 
population between those with arthritis (P/E) and those who have positively screened 
MDD and depression (P).  Seniors with arthritis (P/E) seem to respond differently with 
regards to positively screened MDD and depression (P).  The results demonstrated 
conclusive evidence that one cannot count on an elderly patient to have a positive 
perception of depression as it relates to being positively screened for MDD.  Further, it 
would appear that older persons may not disclose whether or not they are depressed in a 
clinical environment.  This becomes important to clinicians and further demonstrated the 
need for clinically valid assessment measures to ensure preventative measures are being 
taken to address elderly depression. 
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CHAPTER ONE: INTRODUCTION 
1.1 PROBLEM STATEMENT 
Depression extends its reach to both the social and economic impact with 
disregard to geographic boundaries.  The World Health Organization (WHO) reports that 
depression is the leading cause of disability as measured by Years Lived with Disability 
(YLDs) and the fourth leading contributor to the global burden of disease in 2000 
("Report on Mental Illness" 2001).  Additionally, in 2012, the WHO identified that 
depression impacts 350 million persons worldwide.  By the year 2020, depression is 
projected to reach second place of the ranking of Disability Adjusted Life Years 
(DALYs) calculated for all ages and for both sexes ("Report on Mental Illness" 2001).  
Economically, depression displays similar crippling statistics as it relates to businesses 
and their ability to sustain productive employees.  Depression results in more 
absenteeism than almost any other physical disorder and costs the U.S. employers more 
than $51 billion per year in absenteeism and lost productivity, not including high medical 
and pharmaceutical bills ("The Societal Promise of Improving Care for Depression" 
2004).   
The critical combination encompassing disability and cost stimulates the focus of 
my concern on the elderly population and its growing numbers within the United States.   
Since 1900, the percentage of Americans 65+ has tripled (from 4.1 percent in 1900 to 
12.8 percent in 2008), and the absolute number of older persons has increased twelve 
times (from 3.1 million to 38.9 million) ("A Profile of Older Americans: 2009" 2009).  
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The elderly population’s massive growth is a tribute to technological and medical 
advances, however the increases in age allow for longer periods of chronic and disabling 
diseases.  Some type of disability (sensory disability, physical disability, or mental 
disability) was reported by 52 percent of older persons in 2002 ("A Profile of Older 
Americans: 2007" 2007). 
Moreover, the elderly adult also has an increased likelihood to suffer from 
arthritis and other rheumatic conditions (AORC) due to the processes of aging.  
According to the Centers of Disease Control and Prevention (CDC), arthritis is the 
leading cause of disability in the U.S. and is associated with substantial activity 
limitation, work disability, reduced quality of life, and high healthcare costs.  Arthritis is 
expected to affect an estimated 67 million adults in the U.S. by 2030 (Hootman & 
Helmick 2006), and a 2003 report generated by the CDC suggests total cost of AORC to 
be $128 billion, 1.2 percent of the gross domestic product (GDP) during that year (Yelin 
et al. 2007).  The CDC also suggests the prevalence of doctor-diagnosed arthritis among 
adults was estimated at 21.6 percent, or 46.4 million persons.   Prevalence was higher 
among women (25.4 percent) compared with men (17.6 percent), older age groups (50 
percent for persons aged >65 years and 29.3 percent for persons aged 45 to 64 years) 
compared with younger age groups (7.9 percent for persons aged 18 to 44 years).  
In 2004, 36.7 percent of noninstitutionalized persons age 65 and older claimed 
their health was good or excellent (Chop 2009).  The majority (80 percent) of elderly 
persons have at least one chronic condition (Chop 2009).  In 2002-2003, the most 
frequently occurring conditions among older adults were hypertension (51 percent), 
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diagnosed arthritis (48 percent), heart disease (31 percent), cancer of any type (21 
percent), diabetes (16 percent), and sinusitis (14 percent) (Chop 2009). 
As the population of the U.S. ages, the portion of that population with AORC and 
MDD will increase.  Appropriate treatment methods are needed to focus both on 
physiologic care as well as palliative care for those suffering from AORC.  My 
hypothesis suggests an increased likelihood for those elderly who suffer from AORC to 
also suffer from major depressive disorder (MDD) if appropriate preventative treatment 
and/or palliative care are not administered.  If treatment is overlooked, the combined 
societal costs to treat elderly persons suffering from both AORC and MDD will be 
significant. 
1.1.1 AGING POPULATION 
Demographics: 
In 1900, only 4 percent, or 1 in 25, of Americans were older than 65 years of age 
(Chop 2009).  In 2008, the older population numbers 38.9 million and represented 12.8 
percent of the U.S. population (over one in every eight Americans).  The number of older 
Americans has increased by 4.5 million or 13.0 percent since 1998, compared to an 
increase of 12.4 percent for the under-65 population. However, the number of Americans 
aged 45-64 – who will reach 65 over the next two decades – increased by 31 percent 
during this period ("A Profile of Older Americans: 2009," 2009).  The population of 
those older than 65 years has increased by more than 2 million people (7 percent of the 
population) since 1990, while the younger-than-65 age group increased by only 4 percent 
(Chop 2009).  A child born in 2007 could expect to live 77.9 years, about 30 years longer 
than a child born in 1900.  Life expectancy at age 65 increased by only 2.5 years between 
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1900 and 1960, but has increased by 4.2 years from 1960 to 2007 ("A Profile of Older 
Americans: 2009" 2009).  Projections for the year 2030 estimate that 22 percent, or 70.2 
million, of Americans will be older than the age of 65.  An even more dramatic aging 
trend exists among those older than 85 years of age, often referred to as the old-old.  This 
age cohort is expected to double – from 4.7 million in 2003 to 9.6 million in 2030 – and 
double again to 20.9 million in 2050 (Chop 2009).  The percentage of persons age 85 and 
over is growing faster than any other age group (Haber 2010) while the average life 
expectancy for an infant born in the United States (U.S.) today is 77 years, a dramatic 
increase from 1900, when life expectancy was 47 years (Hetzel & Leeder 2001). 
1.1.2 DEPRESSION 
Prevalence: 
It is estimated that by 2030, more than 15 million older adults will experience a 
mental illness. That is nearly double the current number (Jeste et al. 1999).  One-quarter 
of today’s older adults experience some mental disorder, including dementia.   About 16 
percent have psychiatric disorders, and about 10 percent have dementia. A third of those 
with dementia exhibit psychosis and/or depression, and they represent about 3 percent of 
the total elderly population (Jeste et al. 1999).  An estimated 46.4 percent of Americans 
will experience some form of mental illness in their lifetime (Kessler et al. 2005).  Given 
a current U.S. population of more than 305 million, that figure represents an estimated 
141 million Americans. 
Lifetime prevalence of depressive disorders range from 5 percent to 17 percent 
(Williams et al. 2002) and depression is projected to become the second leading cause of 
disability worldwide by the year 2020.  Prevalence estimates of depression vary based on 
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the particular dataset, control variables, and the analysis/impact of comorbid 
relationships.  The risk of depression in the elderly increases with other illnesses and 
when the ability to function becomes limited.  Estimates of major depression in older 
people living in the community range from less than 1 percent to about 5 percent, but 
rises to 13.5 percent in those who require home healthcare and to 11.5 percent in elderly 
hospital patients (Hybels & Blazer 2003).  A lifetime prevalence rate for major 
depression of 16 percent was identified for those in age ranges between 18 and above 
(Kessler et al. 2003).  It was also determined that all age ranges below 60 years of age 
were more likely to experience lifetime major depression than those 60 years and above 
(Kessler et al. 2003).  Moreover, another study also suggested the lifetime prevalence of 
major depression was 17 percent, however, the age ranges used were 15-54 years of age 
(Blazer 1994).  A separate study focused on nursing home patients while producing a 
major depression prevalence rate of 17 percent. (Davison et al. 2007).  While other 
studies identify point estimates, 30-day prevalence rates, and 12-month instances of 
major depression, the focus of this study is on the older population, and the lifetime 
prevalence rates of major depression as it related the DSM-IV criteria-based 
measurements. 
Chronic Conditions/Comorbidity: 
The most likely causes of depression in later life are the loss of a spouse or other 
family support, chronic medical conditions and pain, loss of functional independence; 
and difficulty adapting to changing circumstances within the home, family, or living 
situation (Lantz 2002).  These emotional and physical losses not only can lead to 
depression, but depression in turn can lead to disease, physical decline, and disability 
 6 
 
(Brenes et al. 2008).  Social phobia was the most common comorbid disorder among 
elderly with depression, and depression was the most common comorbid disorder among 
the elderly with any of the anxiety disorders (Cairney et al. 2008).  Although comorbid 
relationships exist and are well documented between depression and physical health 
conditions and dementia, comorbid relationships also exist with regards to anxiety in the 
elderly population (Cairney et al. 2008).  Comorbid anxiety disorder diagnoses were 
present in nearly 51 percent of patients with major depression (Fava et al. 2000).  
Comorbid anxiety disorders both precede and follow major depression while their 
influence on depression remains apparent (Fava et al. 2000).  Causality, from an 
epidemiological standpoint, is difficult to identify given the subjective diagnosis within 
psychological evaluation.  It is important to recognize that comorbid psychological 
effects exist within diagnosis without particular understanding of causality. 
1.1.3 ARTHRITIS 
Prevalence: 
Arthritis is the nation’s most common cause of disability and comprises more than 
100 different rheumatic diseases and conditions, the most common of which is 
osteoarthritis.  Arthritis affects all race and ethnic groups: 36 million whites, 4.6 million 
blacks, 2.9 million Hispanics, 280,000 American Indians/Alaska Natives, 667,000 
Asian/Pacific Islanders, and 469,000 multiracial/others (Bolen et al. 2010).  According to 
the CDC, 46 million (22 percent) of adults have self-reported doctor-diagnosed arthritis 
and 19 million (9 percent of all adults) have arthritis and arthritis-attributable activity 
limitation.  By 2030, 67 million (25 percent) adults aged 18 years and older will have 
doctor-diagnosed arthritis and estimated 25 million adults (37 percent) of those with 
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arthritis will report arthritis-attributable activity limitations.  These results were analyzed 
by the CDC in review of the National Health Interview Survey (NHIS) from data 
collected between 2007-2009 (Health Data Interactive 2011). 
Costs/Impact: 
In 2003, the total cost of arthritis was $128 billion, including $81 billion in direct 
costs (medical) and $47 billion in indirect costs (lost earnings) [Yelin et al. 2007].  This 
total is equal to 1.2 percent of the 2003 U.S. gross domestic product.  Each year, arthritis 
results in 992,100 hospitalizations and 44 million outpatient visits.  8.2 million working 
aged U.S. adults (about 1 in 20) report work limitations due to arthritis or joint symptoms 
while Blacks and Hispanics with arthritis have almost twice the prevalence of work 
limitation and severe pain compared to Whites (Theis et al. 2007). 
1.1.4 PURPOSE OF THE STUDY 
The purpose of this study is to identify those positively screened for major 
depression within the older population (> 64 years of age) and identify whether or not the 
older population are more susceptible to major depression (MDD) if they acknowledge 
being diagnosed for arthritis (E) by a physician in the past twelve months or perceive 
themselves to have some form of arthritis(P).  The dissertation will also suggest the 
unique sense of its contribution with regards to the identification of practitioner-based 
concerns and the particular variance from clinical diagnosis through differential diagnose 
(DSM-IV requirement) by substituting instead of complementing treatment decisions by 
utilizing assessment tools.  The study will also identify the differences between those 
who report being told they have been diagnosed arthritis from a physician and those who 
perceive they suffer from the condition of arthritis.   Additionally, the study will control 
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for factors which are correlated to or may influence the results while attempting to secure 
both validity and reliability within the study design. 
1.1.5 SIGNIFICANCE OF THE STUDY 
The proposed research makes the following contributions:  First, the study follows 
a medical model approach by utilizing the exact criteria from the DSM-IV to identify 
those elderly persons who suffer from major depression.  This is quite different from the 
subjective questioning of the patient given that the exact diagnostic criteria determine the 
patient’s diagnosis and not the subjective response of the patient.  Secondly, the sample 
size is large enough to be representative of the entire U.S. population.  This provides a 
representative outcome-based study that can be generalized across the population of the 
nation for which the sample was drawn. The study will also provide clarity regarding a 
descriptive account and variance between an individual’s perception (P) of feeling 
depressed and meeting the actual DSM-IV criteria for MDD.  Finally, the NESARC 
dataset provided many control variables which nearly match the alternate risk factors for 
the interaction between major depression and arthritis.  These variables will be controlled 
for in order to best represent the “true relationship” between major depression and 
arthritis.   
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CHAPTER TWO: LITERATURE REVIEW 
2.1 CONTRIBUTIONS OF THE STUDY 
This dissertation will attempt to examine the intended elements within the DSM-
IV (APA 2000), as it relates to Major Depressive Disorder (MDD) and express concerns 
for the field given the current standardized assessments and their reliance with regarding 
to evaluation, treatment, and referral.  Additionally, as technological advances in 
pharmacological dependency in treatment has increased, the impact regarding drug 
interactions, as well as specificity of psychotropic medications, has created a systemic 
concern for both patient safety as well as overall effective treatment within the mental 
health community.  A focus on technological innovation and clinical management in 
mental health practice and policy would provide an improvement in overall treatment 
effects.  This is dependent on both clinical adherence (appropriate diagnosis/treatment 
recommendations), as well as patient adherence (particularly in pharmacological 
interventions).  Both should be measured and accounted for, while clinical interventions 
should utilize similar technologically managed care systems to prevent any future 
medical errors to include lack of treatment, under-treatment, mistreatment, and 
overtreatment in mental health clinical practice settings, as described by the American 
Psychiatric Association (APA). 
Moreover, this dissertation selected a specific nationalized dataset (NESARC) 
including those >64 years of age to evaluate MDD (descriptively), as it relates to the 
perception (P) of being “depressed” (self-reported) and those who positively screen by 
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DSM-IV criteria (E) for MDD.  This dissertation is attempting to establish the case 
through a nationalized sample that perhaps a perception of being “depressed” in primary 
care may be enough of an indicator to establish rationale to begin the evaluation, 
treatment and referral process review given that much relies on the “diagnostic” 
processes (differential diagnosis as suggested by the DSM-IV) and the need for 
“screening” and not reluctant tendencies to “assess” in primary care and ensure that the 
clinical standards and DSM-IV standards are being met and not the sub-categorical 
categorization of an assessment created from the DSM-IV standards itself.     
The study will attempt to provide detailed results between the perception of being 
depressed (P) and positively screened MDD diagnosis of the DSM-IV.  Additionally, 
those either perceived to be suffering from arthritis (P) or those self-reporting to have 
been diagnosed by a physician for arthritis (E) with be studied providing data regarding 
the comorbid conditions between MDD and arthritis and their correlation along with the 
need to establish collaboration in evaluation, treatment, and referral (particularly focus on 
the diagnosis and psychopharmacologic recommendations [between and within]) in order 
to ensure that the right care, at the right time, at the right cost (Triple Aim) is done; 
ensuring patient safety and quality. 
In 2011, the American Psychiatric Association updated their “Practice Guidelines 
for Treating Major Depressive Disorder (MDD)” (APA 2011) for which much of the 
substantive support of the literary response and recommendations will be added within.  
However, the “gold standard” for treatment guidelines and the need for clinical training 
and competent decision-making (to include differential diagnosis) originates and follows 
the recommendations of the DSM-IV (APA 2000).  It is important to note that the DSM-
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V (APA 2013) was officially publishing in 2013; following a review of MDD and mood 
disorders, no significant changes impacting evidence-based decision making or 
differential diagnosis requirements were made concerning MDD or the categorization of 
mood disorders. 
The study research question (Q1) and hypotheses (H1 – H3) can be found in 
Section 2.14. 
2.2 THE EPIDEMIOLOGY OF MDD 
Early on, depression was viewed as a deficiency involving neurotransmitters, 
particularly the “monoamines” serotonin , norepinephrine, and dopamine (Julien et al. 
2011).  There is also evidence of alterations of several neuropeptides, including 
corticotropin-releasing hormone (DSM-IV 2000).  In some depressed individuals, 
hormonal disturbances have been observed, including elevated glucocorticoid secretion 
(e.g., elevated urinary free cortisol levels or dexamethasone nonsuppression of plasma 
cortisol) and blunted growth hormone, thyroid-stimulating hormone, and prolactin 
responses to various challenge tests (DSM-IV 2000).  Attention has now shifted on 
intracellular processes, such as second messengers, and their function in the neuron.  Two 
of these second messenger functions are (1) to protect neurons from damage due to injury 
or trauma and (2) to promote and maintain the health and stability of newly formed 
neurons (Julien et al. 2011).  This new way of “second messenger” thinking is referred to 
as neurogenic theory of depression (Julien et al. 2011).  Neurogenic theory believes (1) 
existing neurons are able to “repair” or “remodel” themselves and (2) the brain is capable 
of making new neurons.  The hippocampus is where attention, concentration, and 
memory is formed and the repair or creation of new neurons adds to the field of 
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neuroscience theory (Julien et al. 2011).  Stressful situations can reduce hippocampal 
function and damage existing neurons (Julien et al. 2011).  Antidepressants are known to 
repair neurons and increase neuron creation (Julien et al. 2011).  The second messenger 
system targets the cAMP response-element-binding protein (CREB) [Julien et al. 2011).  
CREBs protein increases in the hippocampus during chronic antidepressant treatment 
further support the second messenger generation of new neurons (Julien et al. 2011).  
Depression beginning in late life is associated with alterations is brain structure, 
including periventricular vascular changes (DSM-IV 2000).    
2.3 THE DSM-IV CRITERIA FOR MDD (IN CONTEXT) 
The DSM-III (1983) was introduced to provide an evidence-based categorization 
of mental illness in which highly trained clinicians could have a standardized method of 
communicative collaboration and diagnostic criteria.  The practical purpose for this 
development was to bridge mental health with physical health for which physicians 
utilized objective evidence (medical modeling) to diagnose the physical ailments of 
persons and the overall combined health (physical and mental) were becoming important 
as the development of treatment methods (pharmacology) could provide effective 
interventions for medical and psychological patients alike.  The DSM-IV (2000) was then 
expanded upon to meet the growing body of evidence within mental health treatment 
along with the rapidly expanding technological interventions (pharmacology) available to 
those health practitioners for which whom would have more treatment choices and 
selections to make and determine (diagnose/treatment) including a collaborative approach 
to both physical and mental health treatment.  With the latest version of the DSM series 
arriving this year (DSM V 2013), it would seem that there are relative concerns regarding 
 13 
 
both the utilization of all practitioners and the DSM standards and practices, as it relates 
to the diagnosis (specificity) and its impact on treatment (pharmacology) with an ever-
increasing focus pharmacologically on specificity and intensity of drug selection and its 
interactions with other physical and mental health medications selected for treatment. 
Since the NESARC dataset utilized the DSM-IV, I will discuss the interpretive 
intentions of the DSM authors to best describe my dataset.  It is important to note that the 
DSM-IV cautions the use of categorization for diagnosis, however, it does not caution 
against its use to utilize for research and educational purposes.  The DSM-IV authors 
express their sincere acknowledgement that the manual is the be utilized by highly skilled 
clinicians in order to be understood as a diagnostic tool; this is given to its “ruling out” 
etiology based on phenomenological ordering and the need to fully understand its 
intention to review and fully consider the concept of differential diagnosis.  Additionally, 
the DSM-IV requires the understanding of specificity in diagnostic decision-making, 
requiring the coding to extend past the differential diagnostic process into adding 
“subtypes” and “specifiers”.  This is most important, as later pharmacological 
recommendations are not only made based on the diagnosis (most assessments test), 
however, it must be differentially diagnosed, sub-typed, and have inclusion of specifiers 
(where needed).  The DSM-IV states, “subtypes define mutually exclusive and jointly 
exhaustive phenomenological subgroupings within a diagnosis” and “specifiers are not 
intended to be mutually exclusive or jointly exhaustive” (DSM-IV 2000).  This fact will 
be important, as I fully explain the diagnostic intentions of the manual and utilize MDD 
and the “ruling out” process of differential diagnosis. 
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From a larger perspective, from beginning to end, the classification of a patient 
would be evaluated using a multiaxial assessment (Axis I – IV).  The following are the 
categorical alignment of each axis a clinician is to review in order to conduct a full and 
proper assessment: (1) Axis I – Clinical Disorders (2) Axis II – Personality Disorders (3) 
Axis III – General Medical Conditions (4) Psychosocial and Environmental Problems (5) 
Global Assessment of Functioning [GAF].  The primary diagnosis typically reviewed is 
clinical and the Axis III-IV are usually viewed as co-occuring or secondary diagnoses.  
However, it is important, as in physiological conditions, to understand how each 
condition may interact along with the treatment modality considered or previously 
administered (therapeutic or drug interactions).  It is also critical to understand that each 
one of these conditions and its diagnosis must be clinically reliable and valid in order to 
effectively administer and monitor pharmacological treatment.  Traditional assessments 
suggest that if the assessment “measures what it is supposed to measure” it is “valid” and 
if it “consistently measures what it says it is going to measure” it is “reliable”.  This is 
dependent that the instrumentation has accounted for the clinical elements, particularly 
when specificity is so critical for both diagnosis and treatment considerations (see 
Sections 2.4 and 2.5). 
During this review of the DSM-IV, I am simply going to review the complexities 
of the category of “mood disorders” and the specific diagnosis of “MDD” (subcategory 
within “mood disorders”).  This is appropriate given our study question and hypotheses, 
as well as a case review depicting the need for a “screening” tool (DSM-IV) in context 
instead of the clinically used assessments tools (see Section 2.4).   
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“Mood disorders” consist of the following sub-categorized “depressive 
disorders”: (1) Major Depressive Disorder (MDD); (a) Single episode (b) Recurrent; (2) 
Dysthymic Disorder (3) Depressive Disorder Not Otherwise Specified (NOS).  “Mood 
disorders” also consist of subcategorized “bipolar disorders”: (1) Bipolar I Disorder; (a) 
single manic episode (b) most recent episode hypomanic (c) most recent episode manic 
(d) most recent episode mixed (e) most recent episode depressed (f) most recent episode 
unspecified; (2) Bipolar II Disorder (3) Cyclothymic Disorder (4) Bipolar NOS (5) Mood 
Disorder Due to General Medical Condition (6) Substance Induced Mood Disorder (7) 
Mood Disorder NOS.  It is important to note the following three issues: (1) each of these 
sub-conditions could have a detailed listing of specifiers to review (2) particular medical 
conditions (neurological such as Parkinson’s Disease, Huntington’s Disease, Multiple 
Sclerosis, Stroke, and Alzheimer’s Disease) have been linked to these particular 
diagnoses [coded on Axis I and III] (3) differential diagnosis needs to take place to 
include a collaborative review of all medications prior to treating with pharmacological 
intervention(s).   
Within the MDD diagnosis, all of the following diagnoses need to be “ruled out” 
prior to reviewing criteria for the diagnosis of MDD: (1) mood disorder due to general 
medical condition (2) substance-induced mood disorder (3) dementia (4) manic episodes 
with irritable mood or mixed episodes (5) attention-deficit/hyperactivity disorder 
[ADHD] (6) adjustment disorder with depressed mood (7) bereavement (8) depressive 
disorder NOS [for those who do not meet criteria for duration or severity].  Again, each 
suggested diagnosis needs to be expanded upon by sub-type and specifier in order to truly 
“rule out” all DSM differential priorities indicated.  Additionally, given the elderly cross-
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sectional sample within the study, “due to general medical condition”, “substance 
induced mood disorder” (to include prescribed medical interactions) and “bereavement” 
may be of particular interest for consideration.  Next, five of nine categories would need 
to be “met” (see Table 3.1) to include the following conditions: (1) symptoms do not 
meet criteria for “mixed episode” (2) symptoms cause clinically significant distress or 
impairment in social, occupational, or other important areas of functioning [GAF] (3) 
symptoms are not due to direct physiological effects of a substance [drug of abuse or 
medication] or general medical condition [link to MDD] (4) symptoms are not better 
accounted for by bereavement [loss of a loved one, symptoms persisting longer than two 
months or characterized by marked functional impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation] 
(DSM-IV 2000).    
The DSM-IV also identifies the need for most mood disorders to provide both 
episodic and course specifiers.  This is particularly important to know when attempting to 
prescribe medications considering that an accurate diagnosis identifying both a cross-
sectional identification of the particular issue and its severity as well as a longitudinal 
(cyclical) history of stated diagnosis is needed.  The DSM-IV provides “decision trees” 
for clinical assistance for each category of disorders.  These are added as appendixes near 
the end of the manual in order to assist clinicians in proper diagnostic decision-making 
(both clinical and family practice) and care planning.  
2.4 QUALITY PROBLEMS IN COMMONLY USED ASSESSMENTS 
A review of both the American Psychiatric Association (APA), “Practice 
Guidelines for Treating Major Depressive Disorder (MDD)” [2010] and the American 
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Academy of Family Physicians’ (AAFP) subsection regarding “Depression and Bipolar” 
[2012] treatment and diagnostic recommendations leave much concern within regard to 
the absence of both highly skilled clinical diagnostic review (partnered psychiatrist) and 
the criteria-based assessment tools currently being accepted into practice.  Many of these 
assessment tools have been adapted to meet the ever-growing prevalence in mental health 
concerns and the additive treatment modalities (pharmacology).  Additionally, ever-
increasing documentation requirements have reduced the amount of time physicians have 
with each patient, chronic care and treatment options (both physically, mentally, and a 
combination of both) have expanded the complexities of treatment, and the expansive 
relationship within drug interactions and their “specificity” lead to much concern for both 
patient safety and the streamlining of “standards of practice” to “realities of care”.  
Specificity and drug toxicity are alarming; for which drug developers have reviewed the 
exact dosage, time release, toxicity, and specificity recommendations (which diagnosis 
and subtyping receive what drug) for which abbreviated assessments do not meet the 
recommendations of both the drug developer, the “standards of practice”; leaving 
concerns within the realities of care (lack of treatment, under-treatment, mistreatment, or 
over-treatment).   
This study provides a differential diagnostic review of assessment tools (section 
on the DSM-IV) while questioning abbreviated assessment tools and their interaction 
with the rapid changes in psychopharmacology.  Additionally, this study will attempt to 
show that the perception (P) of either depression, and more specifically, arthritis (P) or 
arthritis (E) evaluated with MDD, is an important difference from previous studies in that 
the focus will be on the “standards of practice” (recognition and screening in a timely 
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fashion for specificity in diagnosis) instead of the realities of care (focused on an 
abbreviated assessment that disregards differential diagnosis and the partnering of a 
highly skilled clinician to review [psychiatrist] or the recognition accountability to 
address the need for highly skilled training at all levels below or the need to refer for 
treatment). 
The remainder of this section will address several of the current abbreviated 
assessment tools being utilized to identify MDD in clinical practice.  It is important 
understand that the instruments (as written) cannot replace the highly skilled clinician, as 
they do not account for either physical health (comorbid concerns or drug interactions) or 
other mental health conditions (the “ruling out” process required in the DSM-IV).  
Moreover, the percentiles expressed regarding “sensitivity” and “specificity” do not 
represent the similar terminology described in the DSM-IV (specificity), as the 
assessment is being reviewed for “sensitivity” and “specificity” based on the particular 
questions within the assessment (limited) as they relate to MDD and not the depth of 
diagnosis.  The measurements do not account for inter-relationships within comorbid 
treatment and drug selection, as well as drug “specificity” needed for appropriate 
treatment selection; this is based on the “specificity” of the diagnosis as well as the 
appropriate selection of the “sub-type” and the “specifier” from the DSM-IV.  
The AAFP suggests the first instrument utilized in assessing a patient is the 
Patient Health Questionnaire - 2 (PHQ-2).  Their report and findings suggest that it is as 
effective as the Beck Depression Inventory (BDI) and the Zung Depression Scale (ZDS).  
The reported rate of specificity on this particular assessment tool is 67 percent with a 
sensitivity rating of 97 percent.  The PHQ-2 simply asks the following two questions 
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(related to the two criteria discrediting the diagnosis of MDD in the DSM-IV [must have 
either to have MDD]): (1) little interest (2) feeling down.  There is some variance from 
direct context within the DSM-IV regarding these two questions as the DSM-IV suggests 
content specific to the following two categories: (1) depressed mood [sad/empty] and (2) 
loss of interest or pleasure. 
The AAFP then recommends, if positive, to utilize the PHQ-9.  If the patient’s 
age is >64 years, then administer the Geriatric Depression Scale (GDS) [15 item scale] as 
well; this comes both recommended by the AAFP and the American Geriatric 
Association (AGA).  The PHQ-9 is reported to have a rating of 94 percent sensitivity and 
61 percent specificity.  Following a review of 18 studies (AAFP 2012), the GDS [15 item 
scale] had a sensitivity rating between 74 and 100 while having a specificity rating 
between 53 and 98.  The particular questions within the PHQ-9 had those similar to the 
criteria within the DSM-IV for MDD, however, they divided the responses into four sub-
categories: (1) not at all (2) several days (3) more than half days (3) nearly every day.  
Additionally, the totals of the responses are added to create a final result attempting to 
“detail” the severity of MDD: (1) 1-4 [minimal], (2) 5-9 [mild], (3) 10-14 [moderate], (4) 
15-19 [moderately severe], and (5) [severe].  The GDS [15 item scale] has 15 questions 
in which “yes/no” responses are given; the assessor understands which “yes/no” response 
suggests a positive assessment towards MDD in which > 5 positive responses are 
“suggestive of depression” and > 10 positive responses are “almost always depression”.  
The AAFP then suggests that if either of these assessments are “positive” they should be 
confirmed utilizing the DSM-IV and its criteria.  However, we are making the distinction 
that, given the environment of collaborative and quality care, meeting the “criteria” is not 
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the standard of the DSM-IV.  The standard of the DSM-IV is met through differential 
diagnosis “above and beyond” the standard and the standard requires “sub-typing” and 
“specifiers” for accurate diagnosis.  However, it is important to understand that both the 
assessment options and the AAFP recognize the DSM-IV as the final authority in 
diagnostic care.   
The APA focuses primarily on the four assessments: (1) PHQ-9, (2) Beck’s 
Depression Inventory [BDI], the Hamilton Rating Scale for Depression [HAMD], and the 
GDS.  Given the AAFP recognized both the PHQ-9 and the GDS, we will not duplicate a 
descriptor or the elements needed to understand both sensitivity/specificity and the 
scoring of these assessments.  The BDI is a 21 item assessment, quite detailed [scaling 0-
3], with an overall scoring system as follows: (1) 1-10 [ups/downs considered normal], 
11-16 [mild mood disturbances], 17-20 [borderline clinical depression], 21-30 [moderate 
depression], 31-40 [severe depression], and over 40 [extreme depression].  The BDI was 
the most comprehensive assessment reviewed, however, it did not account for 
“differential diagnosis” within the instrument nor “rule out” the requirement to utilize the 
DSM-IV for this purpose following a positive assessment.  The HAMD is a 21 item 
assessment tool that includes similar scales as the BDI.  Conversely, the HAMD includes 
some stratification to account for things such as personality disorder, somatic conditions, 
and anxiety.  However, it is important to note that none of the additional generalized 
itemization is enough or conclusive to include diagnosis in these areas.  The scales 
included vary from smaller scales, such as 0-2 responses generally around secondary 
diagnoses (such as personality disorders, somatic conditions, and anxiety) to more details 
responses, such as 0-4, representing those characteristics surrounding MDD. 
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The most compatible assessment (highly detailed) for clinicians and relative to the 
comorbid complexities to include the review of DSM-IV criteria (including differential 
diagnosis) is the Composite International Diagnostic Interview (CIDI 3.0) developed by 
Dr. Ronald Kessler as supported by the World Health Organization (WHO).  This 
sectional reporting tool was developed for researchers in order to administer DSM-IV 
appropriately reviewed diagnosis criteria to provide an actual account of validity in a 
large researched population sample (later reviewed within the European Study of the 
Epidemiology of Mental Disorders [ESEMeD 2007].  Although comprehensive in nature, 
it was primarily constructed from research conditions or administered by highly trained 
interviewers in sections.  Additionally, the administration of sectional assessments are 
time consuming making it difficult to clinically administer in a primary care setting or 
one in which practitioners are assessing patients within a limited window of time.     
2.5 QUALITY IN PSYCHOPHARMACOLOGY AND THE DIAGNOSIS 
The purpose of this section of the dissertation is to identify the solutions, 
challenges, and side effects of psychotropic and antidepressant drugs used in the 
treatment of MDD.  The brief review of psychopharmacology (science of how drugs 
affect the body) [Julien et al. 2011] is needed in order to fully understand that particular 
drugs and their effects in “intensity”, “release”, and “specificity” are relative to those 
overall positive and negative effects in treatment.    
“Pharmacokinetics” is the understanding of the basic principles of drug 
absorption, distribution, metabolism, and excretion (Julien et al. 2011). 
“Pharmacodynamics” examines the interactions between drugs and receptors to which the 
drug attach as well as how the attachment results in alterations in cell function and 
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behavior (Julien et al. 2011).  Pharmacokinetics is made up of the four basic processes: 
(1) absorption (2) distribution (3) metabolism (4) elimination (ADME) [Julien et al. 
2011].  Concepts related to the four basic processes are: drug tolerance, drug dependence, 
dosage, intensity and half-life.  These terms have much to do with “time” and the impact 
(effect) of the drug on the cellular processes and the body’s response to such 
interventions.  Drug absorption refers to processes and mechanisms by which drugs pass 
from the external world into the bloodstream (Julien et al. 2011).  Drug distribution is the 
passing across various barriers in the bloodstream to reach its site of action (receptors) 
[Julien et al. 2011].  The processes involved between the kidney and liver within drug 
metabolism and elimination are complex; the important element is to understand that they 
both are involved in metabolism and elimination and their rates of absorption and 
excretion have an impact on overall drug effect.   
Tricyclic antidepressants (TCAs) block the presynaptic transporter; commonly 
referred to in its impact on chemical structures, as newer antidepressants are defined by 
their mechanism of action (Julien et al. 2011).  Some side effects of TCAs are as follows: 
confusion, memory and cognitive impairment, dry mouth, blurred vision, increased heart 
rate, dizziness and urinary retention (Julien et al. 2011).  Monoamine oxidase inhibitors 
(MAOIs) bind to and block the enzyme monoamine oxidase; this enzyme metabolizes 
and regulates the amount of the biogenic amine transmitters in the presynaptic nerve 
terminal (Julien et al. 2011).  TCAs and MAOIs are referred to as first-generation 
antidepressants.  In the late 1980s, selective serotonin reuptake inhibitors (SSRIs) were 
developed, the first being fluoxetine (Prozac) [Julien et al. 2011].  Newer drugs have only 
altered side effects and improvements are still needed in the following ways: (1) superior 
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efficacy (2) faster onset of action (3) improved side effect profile (Julien et al. 2011).  It 
is most important to understand that antidepressant medications have a variety of side 
effects that combined with other medications can be significant or dangerous.  
Additionally, the Federal Drug Administration (FDA) has approved specific drugs for 
specific purposes and clinicians should be fully aware of their impact on patients along 
with recommended dosages.  The following drugs are approved by the FDA for the 
treatment of MDD: (1) SSRIs (a) fluoxetine [20-60mg/day] (b) sertraline [50-200 
mg/day] (c) paroxetine [20-60 mg/day] (d) citalopram [20-60 mg/day] (e) escitalopram 
[10-20 mg/day] (2) SSNRI (a) duloxetine [60-120 day] (b) venlafaxine [75-375 mg/day] 
(c) mirtazepine [15-45 mg/day] (d) desvenlafaxine [50 mg/day] (3) NDRI (a) bupropion 
[300-450 mg/day].  The “mg/day” were recommendations made from the APA practice 
guidelines; combined with the FDA approved antidepressant listing.    The practice 
guidelines from the APA (2010) also provides a detailed listing of side effects and the 
numerous antidepressants associated with that particular side effect and treatment of each 
specific side effect.    Lastly, elderly patients are particularly prone to orthostatic 
hypotension and cholinergic blockade; for this reason, SSRIs, SNRIs, and other 
antidepressants should be considered over MAOIs or TCAs (APA 2010); chronic 
conditions in the elderly typically include the need to closely manage comorbid and 
treatment conditions involving both physical and psychological drug interactions. 
2.6 QUALITY STANDARDS IN EVALUATION, TREATMENT AND REFERRAL 
This dissertation attempts to make a clear distinction between the current 
practices of mental health diagnoses and those described as a “standard of care” within 
the DSM-IV and the practice guidelines (2010) outlined by the APA.  Within each 
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assessment previously evaluated, each instrument identified that the DSM-IV standards 
were the overall “standard of care” prescribed by the APA and others alike and act as if 
the overall consensus on evaluations for treatment and referral.  Within the health care 
system, a referral is commonly known as “needed” if the health provider or practitioner is 
uncertain as to what form of treatment is needed to protect both the patient from harm 
(malfeasance) and for the provider to not administer something that is not clinically 
known to add benefit to the patient (beneficence).   
Both the AAFP (2012) and the APA (2010) guidelines suggest the clinician 
administer some form of an accepted assessment in order to validate the diagnosis.  This 
dissertation questions the validity of such assessments and their instrumentation towards 
diagnosis and its impact on the patient if psychopharmacology and prescriptive services 
are needed.  Kessler also expressed concerns later justified with the CIDI results (2007) 
within the ESEMeD sample population (Section 2.7).  The following are the treatment 
recommendations by the APA (psychiatrist management) with regards to MDD: (1) 
establish and maintain a therapeutic alliance [assuming this would include a clinically 
competent referral network based on the DSM-IV and differential diagnosis 
requirements] (2) complete the psychiatric assessment [important that differential 
diagnosis and cognition of comorbid and drug interaction effects] (3) establish the 
appropriate setting for treatment (5) evaluate functional impairment and quality of life (6) 
coordinate the patient’s care with other clinicians (7) monitor the patient’s psychiatric 
status (8) integrate measurements into psychiatric management [review of side effects 
and therapeutic benefits] (9) enhance treatment adherence [suggestion to monitor clinical 
adherence to the DSM-IV standards and differential diagnosis] (10) provide education to 
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the patient and the family [suggest clinical education as well].  Below are the treatment 
recommendations by the APA (acute phase) with regards to MDD: (1) chose an initial 
treatment modality (a) pharmacotherapy (b) other somatic therapies (electroconvulsive 
therapy) [ECT] (c) psychotherapy (d) psychotherapy plus antidepressant medication (2) 
assessing the adequacy of treatment response (3) strategies to address nonresponse.  The 
final treatment phases of recommendation for evaluation and monitoring are the 
continuation phase, maintenance phase, discontinuation of treatment.  The APA 
recommendations also outline details regarding the clinical factors influencing treatment 
as follows: (1) psychiatric factors [types of psychotropic medication and dosage], (2) 
demographic and psychosocial factors [Andersen/House blended framework], and (3) co-
occurring general medical conditions (APA 2010). 
2.7 PRIMARY CARE PHYSICIANS’ ROLE IN MDD 
The details regarding the holistic treatment (physical/mental) is a complex one for 
each of the providers, practitioners, and clinician selected to work together towards the 
overall health of a patient.  Moreover, the task of managing those with chronic and 
comorbid conditions/multiple modalities of treatment is even more challenging for all 
involved.  The primary care physician (PCP) is often the gatekeeper to their patient’s care 
and often is found to be the care provider even in complex circumstances of treatment 
those with mental illnesses.  During the CIDI review of the ESEMeD (2007), only the 
following proportions of those surveyed (N=514) were receiving adequate treatment by 
severity of MDD: (1) mild [12 percent], (2) Moderate [16 percent], (3) Severe [26 
percent], (4) Very Severe [39 percent] (5) Total [22 percent] (Kessler 2007).  Within the 
Psychological Problems in General Health Care (PPGHC) [primary care], 17 percent had 
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depression; within the ESEMeD population sampled, 13.4 percent had major depression 
in primary care (Tylee et al. 2007).  The PPGHC recognized that 49 percent of those 
identified being recognized by the assessment tool criteria as having MDD we not 
recognized by their primary care provider (PCP) [Tylee et al. 2007].  The ESEMed 
identified that 15 percent with mood disorders and 23 percent with anxiety disorders 
(within previous 12 months of a visit to their PCP) did not receive either psychotropic 
medications or psychological treatment (Tylee et al. 2007).  Either collaborative care or 
further extensive training has worked to improve both appropriate diagnosis and 
recognition of mental health conditions in the primary care setting (Tylee et al. 2007).  In 
two studies, the National de la Sante et de la Recaerche Medicale (INSERM] (26,422 
PCPs), and the ESEMed review, only 54 percent and 58 percent respectively, of those 
meeting the criteria of MDD were considered “psychiatric cases” and only 15 percent and 
26 percent respectively received a diagnosis of MDD (Lucrubier 2007).  It is important to 
note that 63 percent of patients with mood disorders and 79 percent of patients with 
anxiety disorders did not seek help over the previous 12 months from their PCP 
(ESEMed) [Nutt et al. 2007].        
2.8 THEORETICAL FRAMEWORK 
2.8.1 FOUNDATIONAL ELEMENTS OF THE FRAMEWORK 
A review of several reports/documents was conducted in determining the best 
overall theoretical framework considering the integration of behavioral and mental health 
services with the current physiological standards of care.  The purpose of this section of 
the dissertation is to outline the reports/documents reviewed chronologically while 
establishing a precedent for integrative care.  Integrative care will be defined as the 
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collaborative care standard consisting of the combination of the following types of care 
and the most optimal referral of such care as determined by both the primary care 
physician and the patient: behavioral, mental, spiritual, and physiological. 
The first portion of this review will come from a health services policy creation 
vantage point, reviewing both the policies of interest concerning integrative care and 
those most related to the NESARC dataset utilized in the dissertation research.  The 
purpose of this section is to demonstrate that the U.S. makes a major shift in policy 
implications regarding integrative health policy and its’ intended national practices 
towards combining mental health as a standard treatment, evaluation, and practice of care 
in the primary setting.  It will also demonstrate its prevalence in prevention services as 
well as a “national call” towards equity in treatment and payment methods which impact 
accessibility of treatment.   
Policy evolution regarding mental health care: 
In 1996, the “Mental Health Parity Act” (MHPA) was established, intending to 
create equality and accessibility (parity) towards treatment for those with mental health 
issues (Department of Labor, Fact Sheet on MHPA 1996).  The law also established that 
financial concerns (insurance) would treat reimbursement for such mental health services 
in an equivalent manner to that of physical health.  In 1999, the U.S. Surgeon General 
established a report entitled, “Mental Health, A Report of the Surgeon General”, which 
outlines the national level concerns of mental health in the U.S. and its impact to both the 
population as well as its financial impacts and trends towards overall financial burden to 
the population.  The collaborative care model (CCM) was then outlined as a national 
standard of care (2002).  Additionally, in 2002, the Substance Abuse and Mental Health 
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Services Administration (SAMHSA) published a report to identifying the comorbid 
correlation between substance abuse disorders and mental health disorders.   
In 2003, the President of the U.S. established a Commission on Mental Health 
which published a report called, “Achieving the Promise: Transforming Mental Health 
Care in America”.  This report outlined specific administrative goals which it hoped to 
achieve while outlining particular steps towards achieving such mental health goals.  The 
President’s report outlined the need for “better coordination between mental health and 
primary health care”, calling for the “treatment for co-occurring disorder to be 
integrated” and to “expand screening and collaborative care in primary care settings”.  
The report also recognized the finding from the World Health Organization (WHO) 
which identified mental illnesses as the leading causes of disability worldwide.  
 In 2008, the “Mental Health Parity and Addiction Equity Act” (MHPAEA) was 
passed to limit insurance companies from establishing excessive deductibles, copays, and 
coinsurance in order to exclude mental health services in practice and ensure elements of 
coverage were covered, more specifically, to include addiction services (Department of 
Labor, Fact Sheet on MHPAEA 2008).  In 2011, the “National Prevention Strategy” for 
public health and health services was authored by the U.S. Surgeon General outlining a 
specified framework inclusive of integrative care and strategies to improve overall health 
care services (HHS, National Prevention Strategy 2011).  Lastly, in 2012, a “Report to 
Congress” regarding the “Compliance with MHPAEA” was conducted to assure 
policymakers that adherence was being given to the law and its added elements from the 
MHPA (1996).   
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Although policy concerns were addressed, practical applications to the 
implementation of collaborative and integrative care were also being established.  In 
1967, the American Academy of Pediatrics (AAP) established the first “medical home” 
model featured around children and those children with “special needs”, later adding 
elements to the “medical home” concept to include all medical services (2002).  In 2007, 
the “Joint Principles” of the patient-centered medical home (PCMH) were established by 
a joint venture lead by AAP, the American College of Physicians (ACP), the American 
Osteopathic Association (AOA) and the American Academy of Family Physicians 
(AAFP) [AAP 2007].  They would include the following principles related to the overall 
care of patients and their health care needs: (1) personal physician (2) physician directed 
medical practice (3) whole person orientation (4) coordinated/integrated (5) 
quality/safety.  Integrative care will be the primary focus regarding the establishment of a 
synthesized conceptual framework between all levels of care.   
In 2008, a study including the concept of the “Triple Aim”, made up of the 
following goals [(1) better care, (2) better health (3) reduced costs] identified that 30% or 
$700 billion of health services were “unnecessary” and further categorized these services 
as “wasteful” (Berwick, D. M., Thomas, T. W., & Whittington, T. 2008).  Berwick’s 
outline of the “Triple Aim” added another perspective that “better care” would include 
both collaborative and integrative health services in order to “reduce costs” while adding 
the elements of “better care” for the population being served.  The “Triple Aim” then 
synthesized its findings with the PCMH model further stimulating the call for 
“Accountable Care Organizations” (ACOs) to produce organizations that (1) increase 
quality through per capita primary care cost monitoring over a continuum of care (2) 
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payments linked to quality improvement (3) more sophisticated performance 
measurement (McClellan M., et al. 2010).  ACOs were formally established in 2006 and 
took national precedence in 2010, as it became a part of the national health care law, the 
Patient Protection and Affordable Care Act (ACA).   
Theories relevant to mental health and mental health care: 
The following is the primary review regarding the theorized conceptual 
framework and its originations.  In 1943, Abraham Maslow developed “Maslow’s 
Hierarchy of Needs” and published his explanation of human motivation within five 
categorical areas: (1) physiological [food, water, shelter, and warmth], (2) safety 
[security, stability, freedom from fear], (3) belonging – love [friends, family, spouse, 
lover], (4) self-esteem [achievement, mastery, recognition, respect], and (5) self-
actualization [pursue inner talent, creativity, fulfillment] (Maslow 1943).  This was a 
sentinel article within the areas of behavioral and psychological behavior, adding initial 
framework depth to the development of human motivation and choices concerning 
integrative health.  In 2011, the Surgeon General’s office published a report called the 
“National Prevention Strategy” (NPS), outlining key strategies going forward in 
addressing the public health concerns.  Collectively, the identified areas within the NPS 
were categorized into the following groups (Figure 2.1): (1) health disparities (2) safe 
environment (3) preventive services (4) empowered people (5) integrative mental and 
behavioral health.  Figure 2.1 (next page) depicts an inverse inter-relationship between 
Maslow’s “Hierarchy of Needs” (1943) and its impact concerning the elements within the 
NPS (2011).  The purpose of Figure 2.1 is to demonstrate a “connection” between 
previously established psychological and behavioral models (Maslow 1943) and current 
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prevention strategies and/or the national prevention strategies of the nation (NPS 2011).  
Within the model, “optimal health” is associated with “self-actualization” (Maslow 1943) 
and “integrative mental and behavioral health” (NPS 2011).  “Co-morbid and chronic 
conditions” are associated with “physiological” elements [such as breathing, food, water, 
excretion] (Maslow 1943) and with “health disparities” in the NPS.  The model suggests 
an improved level of physiological care could exist between “preventive services” and 
“health disparities” (NPS 2011) while the established of physiological care between the 
two categories suggests an increase in quality and “patient safety” (Figure 2.1). 
  
32 
Figure 2.1 Maslow’s Hierarchy of Needs (1943) Comparison Surgeon General’s National Prevention Strategy (2011)
Note: “Patient Safety” becomes the link between Maslow’s Hierarchy of Needs (1943) and Surgeon General’s National 
Prevention Strategy (2011) when Integrative Health Framewo
 
 
 
rks are evaluated and compare 
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In 1969, Elisabeth Kubler-Ross developed another psychological and behavioral 
pivotal theory called, “The Five Stages of Death/Grief”.  The rationale for the evaluation 
of this theory, like Maslow’s, “Hierarchy of Needs”, is two-fold: (1) established as a 
sentinel finding in the field of psychology and behavioral theory (2) indicates an 
established leveling of “health” comparative to psychological elements such as “coping”.  
Additionally, unlike Maslow’s “Hierarchy of Needs”, Kubler-Ross addresses elements of 
“death/grief” which are more centralized to the aging population.  A review of both the 
best practices in death/grieving “coping” and the overall improved (optimal) health status 
of the aging population would seem relevant, as one attempts to frame the correlations 
between mental/behavioral health and physiological elements of health in what national 
policy seems to demand in collaborative and integrative health.  These finding were 
previously discussed and demonstrated to be valid with the review in policy to include, 
but is not limited to, the following: CCM, Triple Aim PCMH, and ACOs. 
Kubler-Ross identifies “The Five Stages of Grief” from beginning to end as such: 
(1) Denial (2) Anger (3) Bargaining (4) Depression (5) Acceptance [Figure 2.2].  The 
process begins with the concept of “coping” through a period of time in “denial” of the 
event itself.  Experience regarding the frequency of death and loss and the preparation for 
the event (trauma) seem to be most likely experientially impacted by the age of the 
person involved.  The more time it takes to navigate through the “five stages” the more 
likely the person impacted will experience an increase in comorbid or chronic elements 
of mental health.  Inclusively, as one “travels” through the five periods, experience by 
experience, the “build up” of one event, toppled upon another, would also increase the 
likelihood of comorbid chronic mental health resulting from multi-level experiences of 
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both unexpected/expectant death through multiple unresolved grief-based events.  
Likewise, the reciprocal version of “The Five Stages of Grief” can be experienced by the 
recently created, “Transitional Self Actualization of Healthy Aging” (2013), in which the 
impact of health on the aging population can be viewed quite differently regarding their 
“transitional” ability to “cope” with death and loss.  First, seniors are more used to 
experiencing death and loss of their friends and close family members, so as their 
experiences “normalize” (more aware) [Figure 2.2, next page], the quicker they adapt to 
the initial stages (given their shortened comparative period of mortality) of “The Five 
Stages of Grief”, the most optimal health they can have for the finite time period of life 
remaining.  Additionally, the expeditious movement through the five stages would seem 
to product a decrease in comorbid or chronic mental health conditions.  As one ages, it 
would appear that the reciprocal elements of the five stages would be dependent on 
“awareness” and “normative” responses to the aging processes and the decisions being 
made through the processes of aging. 
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Figure 2.2 Kubler-Ross Stages of Grief/Death and Unexpected Illness / Transitional Self Actualization for Healthy Aging 
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2.8.2 FRAMING THE FRAMEWORK (ANDERSEN AND HOUSE) 
Abraham Maslow (1943) and Elisabeth Kubler-Ross (1969) framed the 
psychological and behavioral rationale behind a need for the collaborative and integrative 
(blended) framework in primary care and preventive health delivery, even if that was not 
their initial intentions when developing their theories.  Figure 2.1 demonstrated the need 
for integrative mental and behavioral health in modern day medical treatment, given the 
inverse relationship between Maslow and NPS while Figure 2.2 demonstrated another 
inverse mental and behavioral health relationship as it related to the aging process, in 
Kubler-Ross and the “Transitional Self Actualization in Healthy Aging” model.  The 
term “Self Actualization” was attributed to the model established by Abraham Maslow 
and his final stage of human motivation. 
Ronald Andersen (1995) and James House (1981, 2001) were the two theoretical 
frameworks selected to “blend” both a “health services” model (Andersen 1995) [Figure 
2.3] and a social/behavioral model (House 1981 & 2001) [Figures 2.4 & Figures 2.5].  
Andersen’s model focused on four categorical areas in his identification of health 
services utilization: (1) Environment (2) Population Characteristics (3) Health Behavior 
(4) Outcomes (Andersen, 1995).  Under the “environment” category, two subcategories 
emerged: (1) health care system (2) external environment.  The “population characteristics” 
consisted of the following three subcategories: (1) predisposing characteristics (2) enabling 
resources (3) need.  The “health behavior” category was made up of the following two 
subcategories: (1) personal health practices (2) use of health services.  Lastly, the 
“outcomes” category consisted of the following three subcategories: (1) perceived health 
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status (2) evaluated health status (3) consumer satisfaction (Andersen, 1995) [Figure 2.3].  
House’s, “Paradigm of Stress Research” (1981) 
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Figure 2.3 Andersen’s Health Services Conceptual Framework Model (1995)
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Figure 2.4 House’s Conceptual Framework: Paradigm of Stress Research (1981) 
 
 
  
CONDITIONING VARIABLES: Individual or Situational 
(e.g., social support) 
STRESSORS: Objective 
Social Conditions 
Conductive to Stress 
PERCEIVED  
STRESS 
ENDURING 
HEALTH OUTCOMES 
1. Physiological 
2. Cognitive/Affective 
3. Behavioral 
SHORT-TERM 
RESPONSES TO STRESS 
1. Physiological 
2. Cognitive/Affective 
3. Behavioral 
(de
fen
ses
) (coping) 
Note: Solid arrows between boxes indicate presumed casual relationships among variables.  Lighter arrows from the box labeled 
“conditioning variables” intersect solid arrows, indicating an interaction between the conditioning variables in the box at the 
beginning of the solid arrow in predicting variables in the box at the head of the solid arrow as published in House (1981:36). 
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Figure 2.5 House’s Conceptual Framework for Understanding Social Inequities in Health and Aging (2001) 
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 [Figure 2.4] may focus on “stress”, however, the blended framework with utilize 
his thorough flowchart review of both individual and situational conditioning variables 
and their relationship to overall “health” versus “stress”.  Our research would suggest a 
correlational assumption that overall “stress” accounts for a similar relational response to 
the overall “health” of an individual.  The key conceptual components considered within 
House’s model (1981) to create our blended framework are the following: (1) 
conditioning variables, both individual and situational, have an impact on objective social 
conditions impacting overall health (2) both perceived and objective (evaluated) events 
both positive and negative impact short-term level responses to health (3) coping and 
defense mechanisms relative to both objective and perceived events have an impact on 
both short-term response mechanisms and long-term health outcomes (4) short-term 
responses and long-term elements consider of the following subcategorical elements of 
health: physiological, cognitive/affective, and behavioral (House, 1981) [Figure 2.4].  
Additionally, House’s (2001) [Figure 2.5] further contribution to the blended framework 
comes within the following three areas of original contribution: (1) the identification of 
specific explanatory variables accounting for psychosocial risk factors such as: health 
behaviors, social relationships/support, chronic/acute stress, psychological dispositions 
and social roles/productive activities (2) an increased focus of definitive subcategories of 
health outcome to include the following: mortality, institutionalization, morbidity 
(chronic), functional limitations, self-rated health, cognitive function, and depression (3) 
the inclusion of physical/chemical and social environmental hazards (House 2001). 
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2.8.3 FINAL BLENDED FRAMEWORK (ANDERSEN AND HOUSE) 
The final blended framework [Figure 2.6, next page] centers on the Andersen’s (1995) 
formation of categorization (environment, population characteristics, health behavior, and 
outcomes), however, expands them into a more comprehensive and integrative heading 
consisting of the following: (environment, individual/situational characteristics [House 
1981], short-term health behaviors [House 1981 & Andersen 1995], enduring health 
outcome [House 1981 & Andersen 1995].  The category labeled “environment” 
maintained Andersen’s original two categories (health care system and external 
environment), however, the following subcategories were added: (1) under health care 
system (a) access to medical care (b) insurance status (c) enabled resources (2) under 
external environment (a) physical/chemical, social and environmental hazard (House 
2001).  “Enabled resources” were originally sectioned as a subcategory under Andersen’s 
category of “population characteristics” (Figure 2.3), however, given its importance to 
the blended model, “enabled resources” was placed as a subcategory of consideration 
earlier in the blended model under the category of the “health care system” (Andersen 
1995).  In “enabled resources” previous place, “psychosocial risk factors” were 
considered to be the psychological and behavioral element most needed, as it was 
referenced as important by House in 2001.  The elements under “psychosocial risk 
factors” (health behaviors, social relationships/support, chronic/acute stress, 
psychological dispositions, and social roles/productive activities) add needed depth to the 
model attempting to create a most collaborative and integrative model of health to 
include health services research and psychological and behavioral health (House 2001).  
Andersen’s model then has a subcategory of “need” under “population characteristics”.  
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This appeared to be quite broad so the blended model depicted “need” as 
“perceived/evaluated health need”, focusing on physiological need, since “psychosocial 
risk factors” would address the psychological, behavioral, and mental health conditions 
and status (Figure 2.6).   
Andersen’s previously listed category, “health behavior”, was utilized, however, 
given the collaborative and integrated intention of the blended framework, adjusted to 
“short-term health behavior” (Figure 2.6).  Andersen’s subcategory of “personal health 
practices” was comprehensively altered to “decisional / personal health practices”, 
ensuring the inclusion of decision-making and choice reflecting back to address both the 
perception of needed health services.  The next subcategory was entitled, “stressors: 
objective biopsychosocial conditions conducive to diminishing health” given its account 
for the elements associated with the “biopsychosocial” areas of health (House 1981).  
Figure 2.6 depicts the present and short-term health inner-relationships between three 
areas: (1) perceived/evaluated health need (2) decisional/personal health practices (3) 
stressors: objective biopsychosocial conditions conducive to diminishing health.  This 
circular relationship would indicate that the “need” is more than the utilization of health 
services but the preventative understanding (awareness) of multi-faceted conditions 
(social, physiological psychological, biological, behavioral, mental, etc…) and a timely 
response to addressing the collective of those needs (Figure 2.6).  Much of this is due to 
the perceived and evaluated health from multiple sources characterized by the categorical 
heading of “individual and situational characteristics”.  It is vitally important for both the 
individual and the health professional to comprehend, understand, and address these 
multi-faceted health concerns in a comprehensively, communicated, collaborative, and  
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Figure 2.6 Andersen (1995) / House’s (
 
 
1981, 2001) Blended Conceptual Framework Model 
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 integrated way to prevent short-term and long-term negative health outcomes 
and/or comorbid/chronic health conditions.   
 “Perceived / Evaluated Health Need” is a subcategory of both the “short-term 
health behavior” category as well as the final category, the “enduring health outcome” 
category developed through an influence by House (1981).  The continuation of 
“perceived /evaluated health need” demonstrates the short-term to long-term anticipated 
decline in health outcome if the “need” is not perceived by the individual and evaluated 
by the collective of health professionals.  The final category under “enduring health 
outcome” is “actual health” with multiple sub-components taken from both House (1981) 
and Andersen (1995): (1) physiological (2) cognitive/affective (3) behavioral (4) 
consumer/patient satisfaction [Figure 2.6]. 
Most importantly, health is outlined as the integration of elements 1-4 and a 
pathway is drawn best describing prevention and wellness around the awareness of 
“actual health”.  When categories of “environment” and “individual and situational 
characteristics” are collectively understood, the individual can reduce the elements 
impacting their “actual health”.  The model seems to also demonstrate the timely 
dependence on self and health professionals to identify the “perceived/evaluated need”.  
As Andersen projects in his health services research model, the discovery of 
“perceived/evaluated need” can explain the gaps between access, quality, and value in 
health services utilization while House’s contributions can preventatively demonstrate the 
“need” for social, psychological, and behavioral impacts to include physiological 
utilization of health services and link “awareness” to both the individuals seeking care 
and the professionals delivering such care (Figure 2.6). 
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Arthritis (independent variable of interest) is more physiological and seems more 
appropriately represented by a medical model approach.  Regarding arthritis, Andersen’s 
(1995) Health Services Model was selected for review, given its collective account for 
the following categories: health care system, external environment, population 
characteristics, health behavior, and outcomes focus.  However, with concerns to overall 
“outcome”, it would seem that of the three subcategories, (perceived health status, 
evaluated health status, and consumer satisfaction) there were psychological elements 
within an integrated methodology that is needed to fully account for overall health 
outcome in the model.   
House’s (1981 & 2001) models account for the psychological elements 
(psychosocial risk factors) and appeared more comprehensive.  MDD (dependent 
variable) is a psychological disorder for which an appropriate model must be considered.  
The blending of both a physiological, health services model (Andersen 1995) and a 
psychological/behavioral model for which House demonstrated creates a blended 
framework which both match current health policy initiatives and 
collaborative/integrative health care initiatives.  Additionally, the blended framework and 
model will add value in explaining the inter-relationship between those with depression 
and the arthritic condition. 
2.9 CHARACTERISTICS OF THE POPULATION AGED 65 AND OLDER 
This portion of the dissertation will focus on an overall demographic description 
of the older population (to include spending), as well as describing key identified 
descriptive variables to include the following: “age”, “gender” and “health status”. 
Focus on “spending” and its relationship to the blended framework: 
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It is important to focus on several Medicare cross-sectional analyses  of “cost”, 
given the selected blended framework (Andersen/House) and the inclusion of 
“mutability” (Andersen, 1995).  Previously, the health policy trends were outlined to 
describe concepts such as “the Triple Aim” (population health, per capita costs, and the 
experience of care), “PCMH” and “ACOs”.  Additionally, the push for collaborative and 
integrative care models (including behavioral health) impacts the overall medical home 
model, as providers seek to increase services while decreasing costs associated with 
untreated, mistreated, or non-treatment.  This is particularly true with the chronic care 
model and conditions which are most prevalent in this particular population.  As the 
“Triple Aim” suggests, population health must account for “quality” (right treatment, at 
the right cost, at the right time) in order to optimize the “health outcome” while 
minimizing the overall societal impact (scarcity and limited amount of health resources).  
Andersen’s model regarding utilization and health services suggest that “cost” be 
considered first (preventative) under the “health care system” in which “access” provides 
a level of preventative care suggesting that proactive accounts for “cost” become not only 
imperative in current health policy affairs but vital and could even account for many 
“patient safety” issues (Figure 2.1).  If a descriptive account of “cost” by “condition” or 
other primary subset (gender, age, etc…) can provide both preventative (mutable) 
strategies for intervention and/or new and improved methods of assessment (early 
detection) and treatment, now is the time for “cost containment” measures to 
implemented in an effort to redirect health resources while optimizing health outcomes.   
Grouping the older population (most costly group/per capita) and cross-
sectionalizing them by categories is a necessary element for discovery aligned with 
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intervention strategies towards health improvement.  Within the blended framework, the 
focus on both the “perceived” and “evaluated” health of someone more likely to be 
suffering from “depression” (psychological condition) while having “arthritis” 
(physiological condition) both suggests the importance of the integrated care model 
(prevent chronic/costly conditions) while demonstrating that “perceived” health is 
potentially a “call” for required “assessment tools” for those displaying particular 
psychological and physical responses/characteristics in the primary healthcare setting. 
Medicare Demographics and Spending: 
The following information was derived from the CMS National Health 
Expenditure (NHE) report (2011).  The elderly population consisted of more than 42 
million persons over the age of 65.  The per capita spending per enrollee (2011) was 
$10,900 for which the national budget for Medicare was $554 billion.  $231 billion were 
consumed by hospitals (in-patient services), $124 billion were utilized for 
physician/clinical services, and nearly $64 billion were spent on prescription drugs.  
Additionally, the overall budget for Medicaid during this period was $407 billion given 
that over 5 million seniors are dual eligible (utilize both Medicare/Medicaid) [CMS, 
National Health Expenditures 2011].   
Age: (Subcategories of 65-74, 75-84, and 85+): 
According to the US Census (2010), there are over 40 million persons in the US 
aged 65 and over.  Of those, over 21 million persons were between the ages of 65-74 
(youngest old), 13 million were between the ages of 75-84 (middle old), and 5.5 million 
were of an age greater than 85 years (US Census 2011).  Between the periods of 2000 – 
2010, the US population grew by 27 million persons, those 65 and older grew by 5.2 
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million during that period (US Census 2011).  During this same period, those categorized 
as the youngest old grew by 3.3 million person, those middle old persons grew by 700, 
000 persons, and the oldest old grew by 1.2 million persons (US Census 2011). 
Gender/Age: (Subcategories of 65-74, 75-84, and 85+): 
The total population of males in the US over 65 years in 2010 was 17.3 million 
persons, a 3 million person increase over that in 2000 (US Census 2011).  Of those, 10 
million were 65-74 (1.8 million increase), 5.5 million were 75-84 (600,000 person 
increase), and 1.8 million were over 85 years of age; a 550,000 person increase from 
2000 (US Census 2011). 
The total population of females over 65 years of age in 2010 was 22.9 million, a 
2.3 million person increase over 2000 (US Census 2011).  Those women in the age group 
of 65-74 (in 2010) was 11.6 million (increase of 1.5 million persons), the number of 
women between 75-84 was 7.6 million (100, 000 increase), and 85+ women numbered 
3.7 million (700,000 increase) [US Census 2011). 
Health Status (Respondent Reported) by Age [65-74, 75-84, and 85+]: 
The following statistical information regarding health status and age 
categorization was provided by the CDC’s “Health Data Interactive” with sourcing 
information retrieved from the longitudinal collection (1997-2011) of the National Health 
Interview Survey (NHIS).   
Of those older persons 65-74, nearly 42 percent reported having “excellent/very 
good” health, 34 percent had “good” health, however, nearly 21 percent of those 65-74 
report “fair/poor” health.  Seniors in the age group of 75-85 have the following self-
reported health status: 38 percent have an “excellent/very good” health status, 35 percent 
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report having “good” health, while 27 percent disclose having “fair/poor” health.  Lastly, 
those persons 85+ self-report the following: 30 percent have “excellent/very good” 
health, 36 percent report having “good” health, while 34 percent disclose having 
“fair/poor” health.   
2.10 CHRONIC CONDITIONS OF THE US POPULATION 
AGED 65 AND OLDER 
Nationally: 
Elderly beneficiaries, 65-74, are most likely to experience the following chronic 
conditions: 52 percent will have hypertension, 47 percent will also have hyperlipidemia, 
27 percent will have diabetes, 26 percent will have heart disease, 27 percent will have 
diabetes, 25 percent will have RA, 11 percent will have depression and 5 percent will 
have OA (CMS Chronic Conditions Dashboard 2011).  Additionally, those seniors, 75-
84, will experience the following prevalence rates a chronic effects: 66 percent will have 
hypertension, 53 percent will have hyperlipidemia, 38 percent will have heart disease, 34 
percent will suffer from RA, 30 percent will have diabetes, 12 percent will have 
depression, and 9 percent will have OA (CMS Chronic Conditions Dashboard 2011).  
Lastly, for those 85+, the following prevalence rates and chronic medical issues will 
occur: 70 percent will have hypertension, 43 percent will have heart disease, 42 percent 
will have hyperlipidemia, 39 percent will have RA, 16 percent will depression, and 13 
percent will have OA (CMS Chronic Conditions Dashboard 2011). 
By Age, Gender, and Type (All/Dual/Non-Dual): 
Per the remainder of the dissertation, “dual” will be defined as having both 
Medicare and Medicaid insurance while Non-Dual is in reference to those only having 
Medicare as their primary form of insurance.  This will be categorized by the following: 
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dual, non-dual, and “all” (a combination of dual/non-dual).  The population of elderly 
Americans is about 43 million, with approximately 9 million (25 percent) being dual 
eligible and 36 remaining solely provided for under Medicare (US Census 2010).   
Elderly female beneficiaries (all), 65-74, are most likely to experience the 
following chronic conditions: 57 percent will have hypertension, 45 percent will also 
have hyperlipidemia, 26 percent will have diabetes, 29 percent will have heart disease, 26 
percent will have diabetes, 29 percent will have RA, 15 percent will have depression, 15 
percent chronic kidney disease and 7 percent will have OA (CMS Chronic Conditions 
Dashboard 2011).  Comparatively, elderly male beneficiaries (all), 65-74, are most likely 
to experience the following chronic conditions: 51 percent will have hypertension, 46 
percent will also have hyperlipidemia, 29 percent will have diabetes, 32 percent will have 
heart disease, 26 percent will have diabetes, 20 percent will have RA, 7 percent will have 
depression, 12 percent chronic kidney disease and 1 percent will have OA (CMS Chronic 
Conditions Dashboard 2011).    This same group of female beneficiaries (dual) are most 
likely to experience these heightened rates of chronic disease prevalence: 70 percent will 
have hypertension, 52 percent will also have hyperlipidemia, 45 percent will have 
diabetes, 34 percent will have heart disease, 26 percent will have diabetes, 40 percent will 
have RA, 25 percent will have depression, 19 percent chronic kidney disease and 11 
percent will have OA (CMS Chronic Conditions Dashboard 2011).  This same group of 
male beneficiaries (dual) are most likely to experience these heightened rates of chronic 
disease prevalence: 63 percent will have hypertension, 45 percent will also have 
hyperlipidemia, 45 percent will have diabetes, 40 percent will have heart disease, 26 
percent will have diabetes, 26 percent will have RA, 16 percent will have depression, 22 
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percent chronic kidney disease and 2 percent will have OA (CMS Chronic Conditions 
Dashboard 2011).    Within this same group of younger old (65-74) women (non-dual), 
they are most likely to experience the following chronic conditions: 51 percent will have 
hypertension, 47 percent will also have hyperlipidemia, 22 percent will have diabetes, 18 
percent will have heart disease, 26 percent will have diabetes, 28 percent will have RA, 
12 percent will have depression, 8 percent chronic kidney disease and 8 percent will have 
OA (CMS Chronic Conditions Dashboard 2011).  Within the same group of younger old 
(65-74) male (non-dual), they are most likely to experience the following chronic 
conditions: 49 percent will have hypertension, 46 percent will also have hyperlipidemia, 
27 percent will have diabetes, 31 percent will have heart disease, 26 percent will have 
diabetes, 19 percent will have RA, 6 percent will have depression, 11 percent chronic 
kidney disease and 1 percent will have OA (CMS Chronic Conditions Dashboard 2011). 
The middle oldest group (all) of females (74-85) are most likely to experience the 
following chronic conditions: 68 percent will have hypertension, 53 percent will also 
have hyperlipidemia, 26 percent will have diabetes, 32 percent will have heart disease, 29 
percent will have diabetes, 39 percent will have RA, 15 percent will have depression, 16 
percent chronic kidney disease and 14 percent will have OA (CMS Chronic Conditions 
Dashboard 2011).  The middle oldest group (all) of males (74-85) are most likely to 
experience the following chronic conditions: 62 percent will have hypertension, 53 
percent will also have hyperlipidemia, 33 percent will have diabetes, 46 percent will have 
heart disease, 29 percent will have diabetes, 27 percent will have RA, 9 percent will have 
depression, 21 percent chronic kidney disease and 2 percent will have OA (CMS Chronic 
Conditions Dashboard 2011).  The “dual” group of middle-oldest women presented with 
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the following chronic conditions: are most likely to experience the following chronic 
conditions: 78 percent will have hypertension, 52 percent will also have hyperlipidemia, 
45 percent will have diabetes, 43 percent will have heart disease, 26 percent will have 
diabetes, 46 percent will have RA, 24 percent will have depression, 25 percent chronic 
kidney disease and 15 percent will have OA (CMS Chronic Conditions Dashboard 2011).  
The “dual” group of middle-oldest men presented with the following chronic conditions: 
70 percent will have hypertension, 47 percent will also have hyperlipidemia, 45 percent 
will have diabetes, 49 percent will have heart disease, 43 percent will have diabetes, 32 
percent will have RA, 18 percent will have depression, 30 percent chronic kidney disease 
and 4 percent will have OA (CMS Chronic Conditions Dashboard 2011).  The “non-dual” 
group of 75-84 women, presented with the following conditions: are most likely to 
experience the following chronic conditions: 66 percent will have hypertension, 53 
percent will also have hyperlipidemia, 26 percent will have diabetes, 29 percent will have 
heart disease, 25 percent will have diabetes, 37 percent will have RA, 13 percent will 
have depression, 14 percent chronic kidney disease and 13 percent will have OA (CMS 
Chronic Conditions Dashboard 2011).  The “non-dual” group of 75-84 men, presented 
with the following conditions: 61 percent will have hypertension, 53 percent will also 
have hyperlipidemia, 26 percent will have diabetes, 46 percent will have heart disease, 31 
percent will have diabetes, 27 percent will have RA, 7 percent will have depression, 20 
percent chronic kidney disease and 2 percent will have OA (CMS Chronic Conditions 
Dashboard 2011).   
The oldest age women (85+) [all] had these chronic conditions: 73 percent will 
have hypertension, 41 percent will also have hyperlipidemia, 26 percent will have 
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diabetes, 39 percent will have heart disease, 25 percent will have diabetes, 43 percent will 
have RA, 18 percent will have depression, 23 percent chronic kidney disease and 17 
percent will have OA (CMS Chronic Conditions Dashboard 2011).  The oldest age men 
(85+) [all] had these chronic conditions: 66 percent will have hypertension, 45 percent 
will also have hyperlipidemia, 29 percent will have diabetes, 53 percent will have heart 
disease, 25 percent will have diabetes, 31 percent will have RA, 12 percent will have 
depression, 31 percent chronic kidney disease and 4 percent will have OA (CMS Chronic 
Conditions Dashboard 2011).  Those 85+ women who were considered dual also had 
these listed conditions: 77 percent will have hypertension, 37 percent will also have 
hyperlipidemia, 35 percent will have diabetes, 46 percent will have heart disease, 26 
percent will have diabetes, 49 percent will have RA, 28 percent will have depression, 29 
percent chronic kidney disease and 18 percent will have OA (CMS Chronic Conditions 
Dashboard 2011).  Those 85+ men who were considered dual also had these listed 
conditions: 73 percent will have hypertension, 39 percent will also have hyperlipidemia, 
35 percent will have diabetes, 55 percent will have heart disease, 38 percent will have 
diabetes, 38 percent will have RA, 23 percent will have depression, 39 percent chronic 
kidney disease and 5 percent will have OA (CMS Chronic Conditions Dashboard 2011).    
Lastly, those women 85+ considered non-dual also had these diagnosed medical 
conditions: 71 percent will have hypertension, 43 percent will also have hyperlipidemia, 
22 percent will have diabetes, 36 percent will have heart disease, 26 percent will have 
diabetes, 41 percent will have RA, 15 percent will have depression, 21 percent chronic 
kidney disease and 17 percent will have OA (CMS Chronic Conditions Dashboard 2011).  
Lastly, those men 85+ considered non-dual also had these diagnosed medical conditions: 
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65 percent will have hypertension, 46 percent will also have hyperlipidemia, 27 percent 
will have diabetes, 29 percent will have heart disease, 26 percent will have diabetes, 31 
percent will have RA, 10 percent will have depression, 29 percent chronic kidney disease 
and 3 percent will have OA (CMS Chronic Conditions Dashboard 2011).             
2.11 COSTS ASSOCIATED WITH THE OLDER POPULATION 
Nationally, total members by age 65+ dual enrollment (Medicare/Medicaid) and 
non-dual (Medicare only) were accounted for in a cross-sectional analysis (CMS, 
Chronic Conditions Dashboard 2011).  One limitation of the analysis is that it did not 
include an account for “all” members (by age group) to compare between “dual” and 
“non-dual” members.  Those dual members who had 0-1 chronic conditions cost 
$3,023/annually versus non-dual enrollees annual fee of $1,871.  Dual members having 
2-3 chronic conditions utilized $7,687/annually while non-dual members used $5,202 of 
the CMS budget.  Dual members having 4-5 chronic issues utilized $14,337/annually 
while non-dual members used $10,817/annually.  Lastly, dual members with 6+ chronic 
conditions utilized $36,047/annually and non-dual members used $29,312/annually.  
Those older persons 65-74, having 0-1 chronic issue, the dual member utilized 
$1,944/annually while the non-dual used $1,621.  Of this group, they represent 33 
percent of its members and 7 percent of overall spending with the group.  Those older 
persons 65-74 with 2-3 chronic issues, the dual member utilizes $5,847/annually while 
the non-dual represents $4,712 of annual CMS spending per capita.  Of this group, they 
represent 31 percent of its members while spending 19 percent of their overall budgetary 
costs.  Those older persons 65-74 with 4-5 chronic conditions, the dual member utilizes 
$12,629/annually while the non-dual represents $10,131/annually.  Of this group, they 
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represent 22 percent of its members while spending 27 percent of its overall annual 
budget.  Lastly, of those members 65-74 with 6+ chronic conditions, the dual members 
spend $37,236/annually and the non-dual spends $29,176/annually.  Of this group, the 
6+ chronic conditions members represent 14 percent of the total group, however, 
consume 47 percent of all sub-group spending (CMS, Chronic Conditions Dashboard 
2011). 
Of those older persons 75-84 (0-1 chronic issue), the dual member utilized 
$2,084/annually, while the non-dual used $2,103.  Of this group, they represent 23 
percent of its members and 5 percent of overall spending with the group.  Those older 
persons 75-84 with 2-3 chronic issues, the dual member utilizes $5,881/annually while 
the non-dual represents $5,084 of annual CMS spending per capita.  Of this group, they 
represent 33 percent of its members while spending 16 percent of their overall budgetary 
costs.  Those older persons 75-84 with 4-5 chronic conditions, the dual member utilizes 
$12,036/annually while the non-dual represents $10,378/annually.  Of this group, they 
represent 26 percent of its members while spending 27 percent of its overall annual 
budget.  Lastly, of those members 75-84 with 6+ chronic conditions, the dual members 
spend $33,911/annually and the non-dual spends $28,650/annually.  Of this group, the 
6+ chronic conditions members represent 18 percent of the total group, however, 
consume 52 percent of all sub-group spending (CMS Chronic Conditions Dashboard 
2011). 
Those older persons 85+ having 0-1 chronic issue, the dual member utilized 
$3,573/annually while the non-dual used $2,712/annually.  Of this group, they represent 
17 percent of its members and 4 percent of overall spending with the group.  Those older 
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persons 85+ with 2-3 chronic issues, the dual member utilizes $7,471/annually while the 
non-dual represents $6,101 of annual CMS spending per capita.  Of this group, they 
represent 29 percent of its members while spending 14 percent of their overall budgetary 
costs.  Those older persons 85+ with 4-5 chronic conditions, the dual member utilizes 
$13,119/annually while the non-dual represents $11,993/annually.  Of this group, they 
represent 28 percent of its members while spending 26 percent of its overall annual 
budget.  Lastly, of those members 85+ with 6+ chronic conditions, the dual members 
spend $30,547/annually and the non-dual spends $29,293/annually.  Of this group, the 6+ 
chronic conditions members represent 26 percent of the total group, however, consume 
57 percent of all sub-group spending (CMS Chronic Conditions Dashboard 2011). 
2.12 INTRODUCTION TO DEPRESSION 
Depression is an affective disorder, characterized by alterations in emotion or 
mood.  The diagnosis of “major depressive episode” (MDD) is based on the following 
criteria, of which five must be evident daily or almost every day for at least two weeks 
(American Psychiatric Association 1994): depressed or irritable mood, decreased interest 
in pleasurable activities and in the ability to experience pleasure, significant weight gain 
or loss (>5 percent change in a month), insomnia or hypersomnia, psychomotor agitation 
or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, 
diminished ability to think or concentrate, and recurrent thoughts of death or suicide 
(Julien et al. 2011) [Table 3.1].  
Of those ages 65+, nearly 5 million persons are reported to have depression 
(CMS, Chronic Conditions Warehouse 2010).  Depression affects 6 percent to 10 percent 
of older adults in primary care settings and 20 percent to 40 percent of those with chronic 
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medical conditions (Donahue et al. 2011).  In 2000, 9.2 percent of the older population 
was receiving some form of treatment for depression; comparatively, 14.3 percent are 
receiving treatment in 2010 (CMS).  According to the CMS, 15 percent of all persons 
over the age of 65 have depression (Chronic Conditions Dashboard 2011).  Of those, 18 
percent are female and 11 percent are male.   
2.12.1 PREVALENCE RATES 
Depression is the most common affective or mood disorder of old age. About 15 
percent Americans who are 65 years or greater suffer from increased depression, and, of 
those, 3 percent to 26 percent are elderly people residing in the community (Cloninger 
2002). The prevalence level of depression is higher among the hospitalized elderly of 65 
years and over at about 23 percent, and ranges from 16 percent to 30 percent among 
nursing home residents. Depression among the elderly can follow a major precipitant 
event or loss and is often related to chronic illness or pain (Boslaugh 2010). 
Of those 65-74, 11 percent have depression, 6 percent only have depression, 27 
percent have 1-2 conditions, 32 percent have 3-4 conditions, and 34 percent have 5+ 
conditions.  Of those 75-84, 12 percent have depression, 2 percent only have depression, 
17 percent have 1-2 conditions, 30 percent have 3-4 conditions, and 51 percent have 5+ 
conditions.  Lastly, those 85+, 16 percent have depression, 1 percent only have depression, 
13 percent have 1-2 conditions, 29 percent have 3-4 conditions, and 58 percent have 5+ 
conditions.  14 percent of women 65-74 suffered from depression, 15 percent of women 
75-84 also had depression, and 18 percent of women 85+ were diagnosed with depression.  
7 percent of men ages 65-74 had depression, 9 percent of men 75-84 suffered from 
depression, and 12 percent of men ages 85+ had depression (CMS, Chronic Conditions 
 59 
 
Dashboard 2011).   
2.12.2 COSTS OF DEPRESSION 
According to a recent study regarding depression in the elderly population, 11.5 
percent of this population has depression (Schneider et al. 2009).  Of the conditions 
measured within the study, the prevalence rate reported was less than only diabetes (24.3 
percent) and heart failure (17.7 percent) [Schneider 2009].  Regarding all mental health 
conditions, the US spent $73 billion of which $19.6 billion dollars was spending within 
Medicare (AHRQ, Medical Expenditure Survey 2010).  Additionally, $24.1 billion were 
for out-patient services, 15.1 billion were spent on in-patient services and $45.3 billion on 
prescriptive medications (AHRQ, Medical Expenditure Survey 2010).  The total 
expenditures for depression by Medicare (2005) were slightly more than $3.2 billion 
dollars and spent nearly $17,000 per year (2005) on those diagnosed seeking treatment 
for depression (Schneider 2009).  An overall budgetary concern for depression must be 
given the population (42 million older persons) [US Census 2010] and the prevalence of 
elderly depression (11.5 percent or 4.8 million) and the overall current annual cost 
reported by Medicare for per capita treatment ($10,900 per enrollee) [CMS, National 
Health Expenditures 2011]; the real projection of cost for depression treatment (point 
prevalence) is $50 billion.  This realized projection of depression under-treatment to 
actual treatment need is 15 times less than of the actualized budgetary commitment of 
$3.2 billion.  Of the conditions measured within the  previous study, the overall per capita 
cost for depression treatment was only less than that for chronic kidney disease 
($26,671), chronic obstructive pulmonary disease [COPD] ($21,409) and heart failure 
($20,525) [Schneider 2009].      
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2.13 INTRODUCTION TO ARTHRITIS 
AORC is the most common cause of disability in the US (CDC; MMWR 2007).  
Arthritis affects 50 million Americans (Murphy et al. 2009) and approximately one in 
five adults in the US reported doctor-diagnosed arthritis between the periods of 2007-
2009 (Flegal et al. 2010); 22% of adults in the US population have arthritis (Cheng et al. 
2009).  By 2030, an estimated 67 million Americans ages 18 years or older are projected 
to have doctor-diagnosed arthritis (Hootman & Helmick 2006).  Of those ages 65+, 
nearly 10 million persons are reported to have RA and 2.3 million to have OA (CMS, 
Chronic Conditions Warehouse 2010).  In 2030, >50% of arthritis cases will be among 
adults older than age 65 years.  However, working-age adults (45–64 years) will account 
for almost one-third of cases (Hootman  & Helmick 2006)  Additionally, 25.9% of 
women and 18.3% men report doctor-diagnosed arthritis (Hootman & Helmick 2006). 
2.13.1 TYPES OF ARTHRITIS 
Osteoarthritis (OA), also known as degenerative arthritis or the wear and tear 
arthritis is a chronic disease that affects the synovial joints. It affects the joint capsule 
containing bone, cartilage and joint fluid. It is a wide spread type of arthritis and 
Conservative estimates indicate that in 2005, over 26.9 million adults in the US suffered 
osteoarthritis (Lawrence, Felson, & Helmick 2008).  
Osteoarthritis targets the smooth cartilage that covers the end of bones to facilitate 
significant movement seen in the joint and hip. One is said to be suffering from OA when 
this smooth cartilage starts to break down. The disease causes the cartilage to wear off 
quicker than the body can repair it leading to bones rubbing on each other hence swelling 
and pain and the hyaluronic acid found in the joint is decreased. 
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Signs and symptoms of osteoarthritis manifest themselves with time. Joint pain 
can be experienced after an activity but goes away with rest; in advancing cases one can 
experience pain during rest. This form of arthritis can appear in two forms idiopathic and 
secondary forms. Idiopathic osteoarthritis is more prevalent in elderly people and seems 
to appear with age and not from a definitive cause. Secondary osteoarthritis is more 
prevalent in young adults and can be as a result of trauma to the joint.  
There are no definitive ways to prevent osteoarthritis but physicians have given 
guidelines to help reduce the progression of the disease through weight loss, aerobic 
exercises, using therapy, glucosamine and increased vitamin B5 intake. This form of 
arthritis mostly affects the hips, spine and knees. According to Meisser (2005), weight 
loss is a must for patients suffering from osteoarthritis as it reduces loads on affected 
joints especially in obese and overweight elderly people. 
Rheumatoid arthritis (RA) is an autoimmune chronic disease that is characterized 
by inflammation of joints and sometimes other body tissues. Autoimmune infections are 
as a result of the body’s immune system failing to recognize a body tissue. It then attacks 
it as foreign. In rheumatoid arthritis, the body’s immune system targets the synovial 
membrane which releases synovial fluid that lubricates the joints. This attack causes the 
membrane to inflame, thicken and erode leading to joint deformities. Although the 
synovial membrane is the primary target, other surrounding tissues or organs can be 
affected by rheumatoid arthritis. 
Rheumatoid arthritis is more common in women than men and affects about 1% 
of the population. Scientist cannot definitively pin point the cause of autoimmune 
conditions like rheumatoid arthritis. Symptoms of rheumatoid arthritis can appear with 
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time but are usually prevalent between the ages of 20-60 years. The severity depends on 
individuals and the earlier the onset of the disease the more harsh and severe it will be. 
Research studies have shown that patients with rheumatoid arthritis are highly prone to 
depression.  
Confusion can arise as to what form of arthritis one suffers from with the many 
symptoms like pain present in both rheumatoid and osteoarthritis. One of the main 
differences is that osteoarthritis is the wear and tear form of arthritis and tends to affect 
the knees and hips; these are large joints bearing a lot of weight. On the other hand 
rheumatoid arthritis tends to affect smaller joints like wrists, feet and hands. 
Another difference is the duration of pain symptoms. In osteoarthritis pain more 
brief lasting a few minutes and sometimes goes away with rest. In rheumatoid arthritis, 
pain and stiffness is more intense and aggravates with rest like in the morning and may 
last for more than half an hour.  Age is a factor concerning both forms of arthritis when 
identifying the duration of pain and its relative intensity. 
2.13.2 PREVALENCE OF RHEUMATOID ARTHRITIS (RA) 
Arthritis is the most common cause of disability in the US (CDC, MMWR 2007).  
According to the CMS, 29 percent of all seniors (65+) have AORC (CMS, Chronic 
Conditions Dashboard 2011) and specific diagnosis of RA impacts more than 1.3 million 
adults (Druss et al. 2000).  Of those within the Chronic Conditions Dashboard (2011), 35 
percent are female and 22 percent are male.  Furthermore, 23 percent are <65, 25 percent 
are between 65-74, 34 percent are between 75-84, and 39 percent are 85+.  Of those 65-
74, 25 percent have RA, 10 percent only have RA, 35 percent have 1-2 conditions, 33 
percent have 3-4 conditions, and 22 percent have 5+ conditions (CMS, Chronic 
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Conditions Dashboard 2011).  Of those 75-84, 34 percent have RA, 6 percent only have 
RA, 27 percent have 1-2 conditions, 35 percent have 3-4 conditions, and 32 percent have 
5+ conditions (CMS, Chronic Conditions Dashboard 2011).  Lastly, those 85+, 39 
percent have RA, 3 percent only have RA, 22 percent have 1-2 conditions, 33 percent 
have 3-4 conditions, and 42 percent have 5+ conditions (CMS, Chronic Conditions 
Dashboard 2011).  30 percent of women 65-74 suffered from RA, 39 percent of women 
75-84 also had RA, and 43 percent of women 85+ were diagnosed with RA (CMS, 
Chronic Conditions Dashboard 2011).  20 percent of men ages 65-74 had RA, 27 percent 
of men 75-84 suffered from RA, and 31 percent of men ages 85+ had RA (CMS, Chronic 
Conditions Dashboard 2011).  
2.13.3 COSTS OF ARTHRITIS 
In 2006, the United States (U.S.) government spent approximately $128 billion 
($80.8 billion in direct costs/$47.3 billion in indirect costs) in expenditures related to 
AORC (Yelin et al. 2007).  For OA and other non-traumatic joint disorders, the US spent 
$62 billion of which $27.4 billion were spent on services rendered to those 65+ in years 
(AHRQ, Medical Expenditure Survey 2010).  Additionally, $40.3 billion were for out-
patient services, 31.4 billion were spent on in-patient services and $17.4 billion on 
prescriptive medications (AHRQ, Medical Expenditure Survey 2010).    
2.13.4 PREVALENCE OF CO-OCCURING ARTHRITIS AND MDD 
Arthritis is strongly associated with major depression (attributable risk of 18.1%), 
probably through its role in creating functional limitation (Dunlop et al. 2004).  
Depression and RA prevalence research results range from 13 percent to 20 percent 
(Morris et al. 2011).  Within a similar study (n=1,793), of those having RA, 18 percent 
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had depression; additionally, 83 percent of those with depression also had anxiety 
(Murphy et al. 2012).  Anxiety was more common in those with RA, as it presented in 31 
percent of those with RA (Murphy et al. 2012).  Only half of the respondents with RA 
and depression or anxiety sought help for their condition over the past year (Murphy et al. 
2012).   
Among adults with arthritis, depression or anxiety, 14.7 percent (5.5 million) 
reported both. Most respondents with depression also had anxiety (84 percent), whereas 
half of those with anxiety also had depression (49.5 percent) [Murphy et al. 2012].  48 
percent of those persons with RA reporting having “a lot” of difficulties dressing or 
bathing themselves were most likely to be suffering from depression (Murphy et al. 
2012). Those persons with “low” confidence in managing their arthritis or joint 
symptions were 3.9 times more likely to suffer from depression than those who had 
“high” confidence in managing their arthritis or joint symptoms (Murphy et al. 2012).  
Those persons with RA with either “no confidence” or “low confidence” to engage in 
moderate physical activity at least 3 times per week were 4.1 and 3.1 times more likely to 
suffer from depression than those who had “high” confidence in engaging in physical 
activity at least 3 times per week (Murphy et al. 2012).  Only 60 percent of men and 53 
percent of women with diagnosed depression, anxiety or both reported pursuing treatment 
for such over the past twelve months; 53 percent of men are seeking treatment for RA 
and 43 percent for women with an arthritic diagnosis (Murphy et al. 2012).   
Patients with RA and depression have worse health outcomes, including poor 
medical adherence, increased health services utilization, pain, disability and death 
(Margaretten et al. 2011).  In patients with RA, poor clinical characteristics and function 
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are associated with subsequent depressive symptoms (Margaretten et al. 2011).  RA 
disease factors associated within depression in RA patients include pain, functional status 
and clinical remission (Margaretten et al. 2011).   
One in 10 adults, > 20 years of age, who positively screened for arthritis had 
experienced a major depressive episode in the previous twelve months (Fuller-Thomson 
et al. 2009).  Those persons with > than two conditions to include arthritis were 2.2 times 
more likely to suffer from a major depressive disorder than those only experiencing 
arthritis (Fuller-Thomson et al. 2009).  Likewise, those persons with > than two 
conditions to include arthritis were 2.1 times more likely to suffer from suicidal ideation 
than those only experiencing arthritis (Fuller-Thomson et al. 2009). 
2.14 RESEARCH QUESTIONS/HYPOTHESIS 
This study will examine one research question and three hypotheses: 
(Q1) What is the relationship between “perceived” (P) depression and those who meet the 
DSM-IV positively screened criteria for MDD?   
(H1) Those persons age 65 and older who report being diagnosed by a physician as 
having arthritis (P/E) will be significantly more likely to be suffering from MDD than 
those who have not been diagnosed with an arthritic condition. 
(H2) Those persons age 65 and older who self-report arthritis (no reported physician 
diagnosis) [P/E] will be significantly more likely to be suffering from MDD than those 
who have not been diagnosed with an arthritic condition. 
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CHAPTER THREE: METHODS 
3.1 DATA SOURCE AND STUDY POPULATION 
 
Data from the National Epidemiological Survey on Alcohol and related 
Conditions (NESARC) 2001-2002 were used to conduct the analysis.  NESARC is a 
nationwide household survey designed and conducted by the National Institute on 
Alcohol Abuse and Alcoholism (NIAAA).  NESARC used a representative sample of the 
civilian, noninstitutionalized adult population in the United States, including all 50 States 
and the District of Columbia. The fieldwork for the survey was completed under 
NIAAA’s direction by trained U.S. Census Bureau Field Representatives who 
interviewed 43,093 respondents, 18 years of age and older in face-to-face household 
settings.  The population of interest in this study consisted of persons age 65 years and 
greater (n=8,205).   The household response rate for the NESARC was 89 percent, and 
the person response rate was 93 percent, yielding an overall response rate of 81 percent. 
("National Epidemologic Survey on Alcohol and Related Conditions," 2001-2002) 
3.2 STUDY VARIABLES 
Dependent Variable:   
Major depression was defined by utilizing diagnostic criteria identified in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the specific 
questions outlined within the NESARC survey.  The diagnostic screening for major 
depression consists of nine criteria in which one of the symptoms present must be either 
depressed mood or loss of interest or pleasure  
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Per the DSM-IV, a respondent must have either (1) depressed mood or (2) a loss 
of interest or pleasure in order to be diagnosed with major depression (Table 3.1).  If this 
requirement is met, the respondent then must respond positively to at least four of seven 
criteria in order to screen positively for major depression. The question which addressed 
the depressed mood criteria was: “In your entire life, have you ever had a time when you 
felt sad, blue, depressed, or down most of the time for at least two weeks?”  The second 
question asked “In your entire life, have you ever had a time, lasting at least two weeks, 
when you didn’t care about the things that you usually cared about or when you didn’t 
enjoy the things you usually enjoy?”  A positive response to this question was coded as 
affirming a loss of interest or pleasure. 
The next four questions addressed the DSM-IV diagnostic requisite for a 
diagnosis of depression of “significant weight loss when not dieting or weight gain (e.g., 
a change of more than 5% of body weight in a month), or decrease or increase in appetite 
nearly every day”.   This criteria was evaluated by a series of four questions: “Lose at 
least 2 pounds a week for several weeks or at least 10 pounds altogether within a month 
other than when you were physically ill or dieting?”, “Lose your appetite nearly every 
day for at least two weeks?”, “Gain at least 2 pounds a week for several weeks or at least 
10 pounds altogether within a month (other than when you were growing or pregnant)?”, 
and “Find that you wanted to eat a lot more than usual for no special reason, most days 
for at least two weeks?”  If the respondent identified that any of the four questions were 
applicable, they were positively coded for standard three (Table 3.1). 
The fourth DSM-IV criteria, “insomnia or hypersomnia nearly every day,” was 
captured within the NESARC survey by three questions: “Have trouble falling asleep 
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nearly every day for at least two weeks?”, “Wake up too early nearly every day for at 
least two weeks?”, and “Sleep more than usual nearly every day for at least two weeks?”  
If the individual responded that any of the three questions applied, they were positively 
coded for standard four (Table 3.1).   
The fifth DSM-IV criterion required a positive response with regard to three 
questions.  The questions were “Move or talk much more slowly than usual, most days 
for at least two weeks?”, “Become so restless that you fidgeted or paced most of the time 
for at least two weeks?”, and “Become so restless that you felt uncomfortable for at least 
two weeks?”  The related DSM-IV criterion state that “psychomotor agitation or 
retardation nearly every day (observable by others, not merely subjective feelings of 
restlessness or being slowed down)” must be met in order to meet the requisite needed for 
diagnosis (Table 3.1). 
The sixth DSM-IV criteria asks the respondent if he/she, “Feels tired nearly all of 
the time or get tired easily most days for at least two weeks, even though you weren’t 
doing more than usual?”  The DSM-IV suggests that “fatigue or loss of energy nearly 
every day” must be met in order to meet the requirements under criterion six (Table 3.1). 
The seventh DSM-IV criterion evaluated the following two questions: “Feel 
worthless nearly all of the time for at least two weeks?”, and “Feel guilty about things you 
normally wouldn’t feel guilty about, most of the time for at least two weeks?”  Again, if 
the respondent answered positively for either of the questions, it was coded as meeting 
the requirement for criterion seven.  The DSM-IV measurement for criteria seven stated 
“feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or guilt about being sick) [Table 3.1].   
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The eighth DSM-IV criterion asked the following two questions: “Having trouble 
concentrating or keeping your mind on things, most days for at least two weeks?”, and 
“Find it harder than usual to make decisions, most of the time for at least two weeks?”  A 
positive response for either question was coded as a positive association with requirement 
eight.  The DSM-IV identifies the eighth measurement as “diminished ability to think or 
concentrate, or indecisiveness, nearly every day (either by subjective account or as 
observed by others) [Table 3.1]. 
The final requisite DSM-IV criterion (ninth) inquired regarding the following four 
questions: “Attempt suicide?”, “Think about committing suicide?”, “Feel like you wanted 
to die?”, and “Think a lot about your own death?”  Any positive response to any of the 
four questions was coded as meeting the requirements for the ninth criteria.  The DSM-
IV identifies the ninth standard as “recurrent thoughts of death (not just fear of dying), 
recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan 
for committing suicide” (Table 3.1). 
Coding was conducted while following the DSM-IV requirements for major 
depression diagnosis.  The DSM-IV states that “five (or more) of the listed symptoms 
have been present during the same two week period and represent a change from previous 
functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of 
interest or pleasure” (Table 3.1).  SAS coding was conducted to ensure that either criteria 
one or two was met while including that at least four of the remaining standards were also 
deemed positive by the respondent.  This allowed for the positive screening of major 
depression within the older population surveyed by the NESARC study. 
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Table 3.1 Coding of Major Depression Criteria Among Population 65 Years and Older, 
NESARC 2001-2002. 
 
Diagnostic 
indicator 
Criteria 
or 
Subset Question (s) Coding 
Depressed mood 1 
“In your entire life, have you ever 
had a time when you felt sad, blue, 
depressed, or down most of the time 
for at least two weeks?” 
Yes 
See Criteria 2 
No 
See Criteria 2 
Loss of interest or 
pleasure 2 
“In your entire life, have you ever 
had a time, lasting at least two 
weeks, when you didn’t care about 
the things that you usually cared 
about or when you didn’t enjoy the 
things you usually enjoy?” 
Yes   
Meet at least 4 of 7 
criteria below 
No (Yes, Criteria 1) 
Meet at least 4 of 7 
criteria below 
No  (No, Criteria 1) 
No major depression  
Weight 3  At least 4 of 7 positive 
Lose Weight 3/1 
“Lose at least 2 pounds a week for 
several weeks or at least 10 pounds 
altogether within a month other than 
when you were physically ill or 
dieting?” 
Yes 
Positive Criteria 3 
No 
Check Subset 3/2-3/4 
Lose Appetite 3/2 
“Lose your appetite nearly every day 
for at least two weeks?” Yes 
Consistent Weight 
Gain 3/3 
“Gain at least 2 pounds a week for 
several weeks or at least 10 pounds 
altogether within a month (other than 
when you were growing or 
pregnant)?” 
Yes 
Positive Criteria 3 
No 
Check Subset 3/4 
Excessive Eating 3/4 
“Find that you wanted to eat a lot 
more than usual for no special 
reason, most days for at least two 
weeks?” 
Yes 
Positive Criteria 3 
No 
Negative Criteria 3 if No 
to all Subsets (3/1-3/4) 
Sleeping Patterns 4   
Trouble Sleeping 4/1 
“Have trouble falling asleep nearly 
every day for at least two weeks?” 
Yes 
Positive Criteria 4 
No 
Check Subset 4/2 
Waking Early 4/2 
“Wake up too early nearly every day 
for at least two weeks?” 
Yes 
Positive Criteria 4 
No 
Check Subset 4/3 
Excessive Sleep 4/3 
“Sleep more than usual nearly every 
day for at least two weeks?” 
Yes 
Positive Criteria 4 
No 
Negative Criteria 4 if No 
to all Subsets (4/1-4/3) 
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Anxious Symptoms 5   
Slowed Speech 5/1 
“Move or talk much more slowly 
than usual, most days for at least two 
weeks?” 
Yes 
Positive Criteria 5 
No 
Check Subset 5/2 
Restlessness 1 5/2 
“Become so restless that you fidgeted 
or paced most of the time for at least 
two weeks?” 
Yes 
Positive Criteria 5 
No 
Check Subset 5/3 
Restlessness 2 5/3 
“Become so restless that you felt 
uncomfortable for at least two 
weeks?” 
Yes 
Positive Criteria 5 
No 
Negative Criteria 5 if No 
to all Subsets (5/1-5/3) 
Fatigue 6   
Fatigue/Lose of 
Energy 6/1 
“Feel tired nearly all of the time or 
get tired easily most days for at least 
two weeks, even though you weren’t 
doing more than usual?” 
Yes 
Positive Criteria 6 
No 
Negative Criteria 6 if No 
to Subset 6/1 
Worthlessness/Guilt 7   
Worthlessness 7/1 
“Feel worthless nearly all of the time 
for at least two weeks?” 
Yes 
Positive Criteria 7 
No 
Check Subset 7/2 
Guilt 7/2 
“Feel guilty about things you 
normally wouldn’t feel guilty about, 
most of the time for at least two 
weeks?” 
Yes 
Positive Criteria 7 
No 
Negative Criteria 7 if No 
to all Subsets (7/1-7/2) 
Cognitive Ability 8   
Concentration 8/1 
“Having trouble concentrating or 
keeping your mind on things, most 
days for at least two weeks?” 
Yes 
Positive Criteria 8 
No 
Check Subset 8/2 
Decision-making 8/2 
“Find it harder than usual to make 
decisions, most of the time for at 
least two weeks?” 
Yes 
Positive Criteria 8 
No 
Negative Criteria 8 if No 
to all Subsets (8/1-8/2) 
Suicide 9   
Attempted 9/1 
“Attempt suicide?” Yes 
Positive Criteria 9 
No 
Check Subset 9/2 
Considering 9/2 
“Think about committing suicide?” Yes 
Positive Criteria 9 
No 
Check Subset 9/3 
Feeling of positive 
death 9/3 
“Feel like you wanted to die?” Yes 
Positive Criteria 9 
No 
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Check Subset 9/4 
Think of own death 9/4 
“Think a lot about your own death?”   Yes 
Positive Criteria 9 
No 
Negative Criteria 9 if No 
to all Subsets (9/1-9/4) 
 
 
Independent Variable of Interest: 
Within this study, there will be two independent variables of interest.  The first 
variable will be the patient’s identifying that they have arthritis without a physician’s 
diagnosis.  The second variable will be the patient’s account that a physician has told 
them they have arthritis.  This will be utilized to examine Andersen’s theoretical 
framework in which the outcome category identifies the important of both the “perceived 
health status” and the “evaluated health status” within the context of the developed 
blended framework.  
Control Variables: 
Both Andersen’s (1995) and House’s (2001) theoretical framework with be 
utilized to describe the “control variables” description.  Andersen’s model provides a 
particular focus on access to health services and includes the following categorical areas: 
environment, population characteristics, health behavior, and outcomes.  Each of these 
categories has particular subcategories that will be evaluated for proper variable 
selection.  Likewise, House’s (2001) model will be utilized to account for variables based 
on categorical elements within the model, focusing more on the psychological and 
behavioral element of wellness and prevention (Figure 2.6).  These categories are as 
follows: race/ethnicity, gender, social/political/economic conditions and policy, 
socioeconomic status, explanatory variables (including medical care/insurance, 
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psychosocial risk factors, and physical/chemical and social environmental hazards), and 
health outcomes.  The aim is to ensure the inclusion of cognitive/behavioral and 
psychological variables into each model (as appropriate) to account for collaborative, 
coordinated, and integrated care to reduce the potential of comorbid and/or future chronic 
care.  Limitations are related to the NESARC dataset and the particular variables 
available for selection and modeling. 
Table 3.2 represents a combination of the blended framework (Figure 2.6) and 
control variable selection.  The description below will focus on the methods for NESARC 
data coding as well as the categorization of the blended framework (categories: (1) 
environment (2) individual & situational characteristics (3) short-term health behavior (4) 
enduring health outcome.  It is also important to note that although we have categorized 
variables the subcategories developed (Table 3.2) blend into like categories, 
demonstrating the potential influence of addressed and non-addressed issues concerning 
health and impacting the enduring health outcome over time.  Lastly, mutability is 
incorporated in the variable classification model (Andersen 1995) showing which 
variables have the potential for intervention within the selection criteria. 
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Table 3.2 Andersen (1995) / House’s (1981, 2001) Blended Conceptual Framework Control Variable Categorization
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Within the category of “environment”, there are two developed subcategories: 
“health care system” and external environment”.  The following two control variables 
were selected under “health care system”, given their direct impact on access: (1) 
medicare (2) private insurance.  The NESARC dataset surveyed the “medicare” variable 
by asking, “currently covered by medicare” with a dichotomous answer of “yes/no”.  
“Dichotomous” in description going forward will mean a “yes/no” response within the 
dataset unless otherwise described.  Likewise, the “private insurance” variable was 
dichotomous and asked, “currently covered by private health insurance”.   
The dichotomous variable “father/mother (alcohol)” will be a recoded variable 
from two dichotomous questions within the dataset, “blood/natural father ever an 
alcoholic or problem drinker” and “blood/natural mother ever an alcoholic or problem 
drinker”.  The newly created variable (parental alcohol) will be coded as (1) none (2) 
either (3) both.  Likewise, “father/mother (depressed) will be recoded from two 
dichotomous questions, “blood/natural father ever depressed” and “blood/natural mother 
ever depressed”.  This newly recoded variable (parental depressed) will be constructed as 
(1) none (2) either (3) both. 
The next category for which control variables need to be described is “individual 
and situational characteristics.”  This section will only describe those variables within the 
“predisposing characteristics” subcategory, although other subcategories blend into this 
category.  The “place of birth” variable identified whether the respondent was born 
within the US or outside the boundaries of the fifty states.  “Race/Ethnicity” was coded 
into the following categories: Non-Hispanic White, Non-Hispanic Black, Hispanic, Non-
Hispanic Other.  All categories inconsistent with selections within the NESARC survey 
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were distributed into the Non-Hispanic Other category.  “Gender” identified whether the 
respondent was male or female.  “Health status” accounted for the perception of the 
respondent’s current health within the following five levels: excellent, very good, good, 
fair, and poor.  The “region” variable divided the geographical area of the US into four 
areas of interest: Northeast, Midwest, South, and West.  “Age” was stratified into the 
following three levels: 65-74 years (youngest old), 75-84 years (middle old), and 85+ 
years (oldest old). 
The third category of evaluation within the blended framework is the “short-term 
health behavior” category.  The following subcategories and elements of subcategories 
(perceived health) will be accounted for in this category both within variable description 
and incremental modeling: (1) stressors: objective biopsychosocial conditions conducive 
to diminishing health (2) psychosocial risk factors (3) perceived/evaluated need (4) 
perceived health (physical).  Within subcategory (1), “troubled” is dichotomous and 
coded as “felt troubled because of way you felt/often wished could get better”.  “Argue” 
is also dichotomous and coded as “had arguments/friction with family, friends, people at 
work, or anyone else”.  “Not do” is dichotomous and accounts as “couldn’t do things 
usually did/wanted to do”.  “Did less”, again is dichotomous, and asks respondent if “did 
a lot less than usual or were less active”.  “Avoid” is dichotomous and is coded as “avoid 
jobs or tasks that deal with a lot of people”.  “Not open” is a dichotomous variable asking 
if the respondent “find it hard to be open even with people you are close to”.  “Not help” 
is dichotomous and asks respondent if “hard to let others help if they don’t agree to do 
things exactly the way you want”.  “Stubborn” is dichotomous and asks “have others told 
you that you are stubborn or rigid”.  “Not close” is another dichotomous variable asking 
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the respondent “are there very few people you’re really close to outside your immediate 
family”.  Lastly, “does not care” is dichotomous and asks “the sort of person who doesn’t 
care about what people think of you”. 
The next subcategory for which variables will be examined is under the 
“psychosocial risk factors” categorization and will be associated with the category of 
“individual and situational characteristics”.  “Depend is coded as dichotomous and asks if 
the respondent “depends on others to handle important areas in life”.  “Drink” refers to 
the consumption of alcohol and was divided into three levels of interest: current drinker, 
ex-drinker, and lifetime abstainer.  “Alone” was recoded to produce a dichotomous 
variable capturing “living alone” or “not living alone”.  “Worry” is a dichotomous 
variable and asked if they “worry a lot about being left alone to take care of self”. 
Another subcategory of short-term health behavior, “perceived / evaluated need” 
will utilize several NESARC dataset control variables.  “Financial hardship” was a 
dichotomous variable that asked if the respondent “experienced major financial crisis, 
bankruptcy, or unable to pay bills on time in last 12 months”.  “DSI/I” (death serious 
illness/injury) Death, Serious Illness/Injury (DSI/I) is a hybrid variable, which takes into 
account if the respondent experienced death or serious illness/injury of a close family 
member or friend within the previous 12 months.  DSI/I is a combination of variables to 
include “death” and “injury” questions within the dataset.  The particular question 
regarding death extracted from the survey was “any family members or close friends die 
in the past twelve months?”  Likewise, the specific question associated with illness/injury 
was “any family members or close friends had serious illnesses or injuries in the past 
twelve months?  Coding was conducted to capture the significance of either of these 
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instances of occurring.  DSI/I is divided into three levels of measurement: none, either, or 
both.  
 “Education” was recoded into the following four levels of educational 
achievement: some high school or less, completion of high school, some college, and 
college graduate.  The original question stratified the sample into fourteen different 
academic standards.  However, the cross sectional nature of this study required the 
recoding of levels in order to maintain sample sizes significant enough to provide 
accuracy.   
The “Income level” variable was based on total personal income and not family 
income.  The NESARC survey stratified total personal income into seventeen identifiable 
categories.  The cross sectional representation of this study required the limiting of 
categorical levels, thus personal income was adjusted into five levels to include the 
following: $0-10,000, $10,001-$20,000, $20,001-$30,000, $30,001-$40,000, and 
$40,001.  “SSI Income” was a dichotomous variable asking the respondent if he or she 
“personally received supplemental security income (SSI) in last 12 months”.   
“Medicaid” is a dichotomous variable and it was determined to be recorded here 
as a “need-based” variable versus under the category of “health care system”, following a 
blended model favoring House versus Andersen’s health services (access) approach.  The 
variable is dichotomous and stated “currently covered by Medicaid” within the survey.   
“Food stamps” was another dichotomous variable included within the “need” 
subcategory.   
“Accomplished less (physical)” asked the respondent “during the past 4 weeks, 
how often accomplished less than would like as a result of physical health”.  The options 
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for response are as follows: (1) all of the time (2) most of the time (3) some of the time 
(4) a little of the time (5) none of the time.  Likewise, the variable “accomplished less 
(emotional)” asks the respondent “during the past 4 weeks, how often accomplished less 
than would have liked as result of emotional problems”.  The options for response are as 
follows: (1) all of the time (2) most of the time (3) some of the time (4) a little of the time 
(5) none of the time.  Another variable, “physical/psychological health” asked “during the 
past 4 weeks, how often physical health or emotional problems interfered with social 
activities”.  The options for response are as follows: (1) all of the time (2) most of the 
time (3) some of the time (4) a little of the time (5) none of the time.  “Pain” was another 
variable of interest asking the respondent “during past 4 weeks, extent to which pain 
interfered with normal work.  The response options were as follows: (1) not at all (2) a 
little bit (3) moderately (4) quite a bit (5) extremely. 
The following variables described are those physiological variables in which the 
respondent “perceives” to have the particular listed ailment.  “Arthritis” is a dichotomous 
variable in which the respondent was asked “had arthritis in last 12 months”.  It is 
important to note here as well that “arthritis” is highlighted (Table 3.2), as it is the 
independent variable of interest within the study.   
“High blood pressure/hypertension” is dichotomous as well and asked if the 
respondent “had high blood pressure or hypertension in last 12 months”.  “Chest pain” 
was another dichotomous variable and the survey inquired if the respondent “had chest 
pain or angina pectoris in last 12 months”.  “Rapid heart” was also a dichotomous 
variable asking if “had rapid heartbeat or tachycardia in last 12 months”.  “Heart attack” 
is dichotomous as well asking if the respondent “had heart attack or myocardial infarction 
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in last 12 months”.  Lastly, “other heart disease” was dichotomous and asked if “had any 
other form of heart disease in last 12 months”. 
The final category reviewed by the blended framework is “enduring health 
outcome”.  Physical health need (evaluated) is included here and will include all the 
physical areas of diagnoses (reported diagnosed by a doctor) in the previous paragraph 
minus the inclusion of “alcohol abuse/dependence” and “nicotine dependence”.  The 
NESARC dataset established both “alcohol abuse/dependence” and “nicotine 
dependence” through the “evaluated” review of coding for diagnoses, much the same as 
seen later, concerning the “evaluated” health (mental) within the dissertation.  “Alcohol 
abuse/dependence” was reported as “alcohol abuse/dependence in last 12 months” with 
responses in coding as such: (0) no alcohol diagnosis (1) alcohol abuse only (2) alcohol 
dependence only (3) alcohol abuse and dependence.  “Nicotine dependence”  is a 
dichotomous variable reported as “nicotine dependence – lifetime”.  .   
“Arthritis (E)” [Table 3.2] is a dichotomous variable in which the respondent was 
asked “did doctor or other health professional confirm diagnosis”.   
“High blood pressure/hypertension (E)” is dichotomous as well and asked if the 
respondent “did doctor or other health professional confirm diagnosis”.  “Chest pain (E)” 
was another dichotomous variable and the survey inquired if the respondent “did doctor 
or other health professional confirm diagnosis”.  “Rapid heart (E)” was also a dichotomous 
variable asking if “did doctor or other health professional confirm diagnosis”.  “Heart 
attack (E)” is dichotomous as well asking if the respondent “did doctor or other health 
professional confirm diagnosis”.  Lastly, “other heart disease (E)” was dichotomous and 
asked if “did doctor or other health professional confirm diagnosis”. 
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3.3 ANALYTICAL APPROACH 
Analytic procedures were conducting by utilizing SAS statistical analysis 
software (Cary, North Carolina) to emulate the requirement within the DSM-IV.  
Frequency distributions were compared prior to and after recoding variables to ensure 
that proper alterations were similar to those originally intended within the NESARC 
survey.  SUDAAN was used to account for the complex weighted sampling structure of 
the NESARC.   
The bivariate analysis of each variable, as it related to major depression, was 
conducted while using both SAS and SUDAAN and the cross-tabulation procedure.  Chi-
squared tests were also conducted to establish the relationship between characteristics 
and DSM-IV criteria-based MDD.  Logistics regression was utilized to produce bivariate 
odds ratios for major depression. 
Multiple logistic regression analysis was conducted using an incremental 
approach to modeling while accounting for variable categorizations within both Andersen 
(1995) and House’s (2001) conceptual frameworks.  The incremental modeling will 
consist of “blending” the conceptualized framework subcategories with the “perceived” 
and “evaluated” variable responses as outlined in Figure 2.6 and Table 3.2.  Individual 
models will be analyzed while providing stabilizing results associated with each of the 
subcategories of interest.  Variable modeling demonstrated the relationship between 
arthritis and having or not having MDD.  
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The formula utilized given the previously listed variables is as follows: 
 
 
Where:     = log of the predicted odds of having major depression; 
     = intercept; 
     = regression coefficient for the independent variable X1; 
     = regression coefficient for the independent variable X2; 
     = regression coefficient for the nth independent variable; 
X1, X2, X3, X4,…….., Xn are independent covariates included in 
the model; and
 
    = error term 
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CHAPTER FOUR: RESULTS 
 
4.1 DESCRIPTION OF THE POPULATION 
Descriptive Characteristics (Predisposing Characteristics): 
There were 8,205 seniors surveyed within the NESARC dataset (2001-02).  Of 
these, 609 reported having arthritis (P/E) [Table 4.1].  Those born in the U.S. accounted 
for 88.5% of those surveyed within the study and 70.5% of those surveyed were 
considered “Non-Hispanic White” [Table 4.1].  When considering gender, 62.2% were 
female and 37.8% were male.  Those responding to have either “fair” or “poor” health 
were 34.8% while those identifying to have “excellent” or “very good” health were 
33.3% (Table 4.1).  Those older persons surveyed to be 65-74 in years of age were 
52.4%, those 75-84 were 36.2%, and those 85+ in age were 11.4%.  Those with “some 
college” or “college graduates” were 47.2% compared to those with “some high 
school/less” and “complete high school” to be 64.7% (Table 4.1).  Seniors reporting to 
have Medicare was 93.0%, Medicaid was 10.5% and private insurance was 56.6%.  
Income levels about $30,001 was reported by 32.6% of seniors while 49.0% elderly 
persons surveyed reported having incomes below $20,000 per year.  Of the older 
population surveyed, 7.4% reported receiving SSI income and 4.7% disclosed receiving 
food stamps.  Financial hardship (previous 12 months) was reported by 3.6% of seniors in 
the survey (Table 4.1). 
Descriptive Characteristics (Biopsychosocial Conditions):  
Seniors within the survey disclosed that 8.0% had biological mothers who were 
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depressed and 4.2% had depressed fathers (Table 4.2).  The elderly sample also reported 
that 1.8% had fathers who were alcoholics and 10.8% had alcoholic mothers (Table 4.2).  
Those who either had lost a family member or close friend (previous 12 months) or had a 
close friend suffering from a serious illness or injury (DSI/I) were 30.4% and those 
whom had experienced “both” were 22.7% in number.  The sample also reported that 
8.0% considered themselves to be “not open”, 15.0% would not ask for help when 
needed, and 29.3% considered themselves to be “stubborn” (Table 4.2).   
Descriptive Characteristics (Medical Comorbidities): 
Seniors experiencing self-reported pain “moderately”, “quite a bit” and “extremely” 
were 35.4% (Table 4.3).  Elderly persons within the sample reporting to have 
hypertension (P/E) were 48.7%, those reporting chest pain (P/E) were 12.7%, and elderly 
persons reporting previously experiencing a heart attack were 3.3% (Table 4.3).  Older 
persons within the survey who reported having a rapid heartbeat (P/E) were 11.5% while 
those reporting any “other heart disease (P/E)” were 8.8% (Table 4.3).  Those persons 
within the survey evaluated (E) for “alcohol abuse only” were 11.6% while those who 
were evaluated (E) for both alcohol abuse and dependence were 2.8% (Table 4.3).  
Seniors within the survey whom were evaluated (E) nicotine dependence were 8.3% 
(Table 4.3). 
4.2 DESCRIPTIVE / BIVARIATE ANALYSIS [MDD] 
Risk Factors (Predisposing and Enabling Characteristics): 
Predisposing and enabling characteristics were controlled for given their potential 
impact of influencing multivariate outcomes with regards to MDD. 
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Those persons experiencing arthritis (P/E) were significantly more likely to suffer 
from MDD [OR 2.00; 95% CI: 1.52, 2.65] than those whom did not suffer from arthritis 
(P/E). Women were significantly more likely to suffer from MDD than men [OR 2.09; 
95% CI: (1.73, 2.53)].  Nearly16 percent of all women were positively screened for MDD 
contrasted with only 8 percent of senior males. 
Those seniors in either “fair” [OR 1.67; 95% CI: (1.26, 2.20)] or “poor” [OR 2.48; 
95% CI: (1.82, 3.37)] were significantly more likely to suffer from MDD than those self-
reporting “excellent” health condition.  Those in “fair” health status and screening 
positive for MDD were nearly 15 percent of the “fair” sample while those in “poor” 
health status screening positive for MDD were nearly 21 percent of those sampled within 
the “poor” health status sub-category.  Comparatively, only 9 percent of those in 
“excellent” health status suffered from MDD (Table 4.1). 
Seniors ages 75-84 were significantly less likely [OR 0.80; 95% CI: (0.67, 0.95)] to 
suffer from MDD than those ages 65-74 (referent group); and those 85+ were also 
significantly less likely to suffer from MDD [OR 0.54; 95% CI: (0.41, 0.71)] than those 
seniors in the referent group (Table 4.1). 
Seniors who reportedly accepted SSI income were significantly more likely to be 
suffering from MDD [OR 1.49; 95% CI: (1.12, 1.98)] than those who did not accept or 
qualify for SSI income.  Likewise, those who reportedly accepted food stamps were 
significantly more likely to suffer from MDD [OR 1.88; 95% CI: (1.30, 2.73)] than those 
who did not accept or qualify for food stamps (Table 4.1). 
Seniors who self-reported financial hardship over the past 12 months were 
significantly more likely to experience MDD [OR 4.00; 95% CI: (2.94, 5.45)].  Those 
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seniors who also report both receiving SSI income [OR 1.49; 95% CI: (1.12, 1.98)] and 
food stamps [OR 1.88; 95% CI: (1.30, 2.73)] were significantly more like to suffer from 
MDD.   
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Table 4.1 Descriptive Characteristics and Risk Factors for Major Depression, persons 65 and older, 2001-2002 NESARC 
 
 Total 
n=8,205 
Frequency / % 
No Major Depression 
n=7,148 
%(se) 
Major Depression 
n=1,057 
%(se) 
OR forMajor 
Depression 
OR (LCL, UCL) p-value 
Hypothesized IV      
Arthritis (P/E)**     0.00 
   Yes 609 (7.4) 78.82 (2.24) 21.18 (2.24) 2.00 (1.52, 2.65)  
   No 7,596 (92.6) 88.17 (0.44) 11.83 (0.44) 1.00  
Predisposing 
characteristics 
     
Origin of birth     0.44 
   U.S. born 7,243 (88.5) 87.67 (0.47) 12.33 (0.47) 0.89 (0.67, 1.19)  
   Non-U.S. born 942 (11.5) 86.41 (1.57) 13.59 (1.57) 1.00  
Race/Ethnicity     0.12 
Non-Hispanic White 5,776 (70.5) 87.44 (0.51) 12.56 (0.51) 1.00 - 
Non-Hispanic Black** 1,355 (16.5) 90.06 (1.07)   9.94 (1.07) 0.77 (0.60, 0.99) 0.04 
   Hispanic 895 (10.9) 87.49 (1.49)  12.51 (1.49) 1.00 (0.74, 1.34) 0.98 
Non-Hispanic other 171 (2.1) 84.64 (2.64)     15.36 (2.64)  1.26 (0.84, 1.89) 0.25 
Sex**     0.00 
   Male 3,104 (37.8) 91.91 (0.59) 8.09 (0.59) 1.00  
Female 5,101 (62.2) 84.43 (0.65) 15.57 (0.65) 2.09 (1.73, 2.53)  
Health status**     0.00 
   Excellent 983 (12.0) 90.45 (1.02) 9.55 (1.02) 1.00 - 
   Very good 1,749 (21.4) 90.66 (0.78) 9.34 (0.78) 0.98 (0.73, 1.31) 0.87 
   Good 2,580 (31.6) 88.45 (0.76) 11.55 (0.76) 1.24 (0.93, 1.65) 0.14 
   Fair** 1,938 (23.7) 85.05 (1.00) 14.95 (1.00) 1.67 (1.26, 2.20) 0.00 
   Poor** 915 (11.2) 79.28 (1.60)  20.72 (1.60) 2.48 (1.82, 3.37) 0.00 
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Total 
n=8,205 
Frequency / % 
No Major Depression 
n=7,148 
%(se) 
Major Depression 
n=1,057 
%(se) 
OR for Major 
Depression 
OR (LCL, UCL) p-value 
Age**     0.03 
   65-74 4,301 (52.5) 86.10 (0.60) 13.90 (0.60) 1.00 - 
75-84** 2,973 (36.2) 88.56 (0.72) 11.44 (0.72) 0.80 (0.67, 0.95) 0.01 
85+** 931 (11.3) 92.02 (0.97) 7.98 (0.97) 0.54 (0.41, 0.71) 0.00 
Region     0.24 
   Northeast 1,684 (20.5) 89.23 (0.95) 10.77 (0.95) 1.00 - 
   Midwest 1,758 (21.4) 87.30 (0.86) 12.70 (0.86) 1.21 (0.94, 1.55) 0.14 
   South 3,135 (38.3) 87.53 (0.75) 12.47 (0.75) 1.18 (0.93, 1.50) 0.17 
   West** 1,628 (19.8) 86.26 (0.95) 13.74 (0.95) 1.32 (1.02, 1.70) 0.03 
Education     0.99 
   Some high school/less 2,645 (32.2) 87.36 (0.82) 12.64 (0.82) 1.03 (0.81, 1.30) 0.80 
Complete high school 2,665 (32.5) 87.66 (0.72) 12.34 (0.72) 1.00 (0.82, 1.23) 0.98 
Some college 1,206 (14.7) 87.59 (1.12) 12.41 (1.12) 1.01 (0.77, 1.32) 0.95 
   College graduate 1,689 (20.6) 87.69 (0.92) 12.31 (0.92) 1.00 - 
Medicare     0.19 
   Yes 7,629 (93.0) 87.40 (0.47) 12.60 (0.47) 1.30 (0.88, 1.94)  
   No 576 (7.0) 90.03 (1.73) 9.97 (1.73) 1.00  
Medicaid     0.45 
   Yes 865 (10.5) 86.54 (1.34) 13.46 (1.34) 1.11 (0.85, 1.44)  
   No 7,340 (89.5) 87.67 (0.50) 12.33 (0.50) 1.00  
Private Insurance     0.71 
   Yes 4,647 (56.6) 87.44 (0.59) 12.56 (0.59) 1.03 (0.87, 1.22)  
   No 3,558 (43.4) 87.78 (0.68) 12.22 (0.68) 1.00  
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Total 
n=8,205 
Frequency / % 
No Major Depression 
n=7,148 
%(se) 
Major Depression 
n=1,057 
%(se) 
OR for Major 
Depression 
OR (LCL, UCL) p-value 
Income level     0.20 
   $0-$10,000 1,709 (20.8) 86.40 (0.91) 13.60 (0.91) 1.13 (0.90, 1.42) 0.29 
   $10,001-$20,000  2,312 (28.2) 86.55 (0.88) 13.45 (0.88) 1.12 (0.90, 1.39) 0.32 
   $20,001-$30,000 1,506 (18.4) 88.27 (0.96) 11.73 (0.96) 0.96 (0.74, 1.22) 0.71 
   $30,001-$40,000 949 (11.6) 89.21 (1.12) 10.79 (1.12) 0.87 (0.66, 1.15) 0.32 
   $40,001-higher 1,729 (21.0) 87.79 (0.90) 12.21 (0.90) 1.00 - 
SSI Income**     0.01 
   Yes 607 (7.4) 82.86 (1.88) 17.14 (1.88) 1.49 (1.12, 1.98)  
   No 7,598 (92.6) 87.82 (0.47) 12.18 (0.47) 1.00  
Food Stamps**     0.00 
   Yes 387 (4.7) 79.29 (3.03) 20.71 (3.03) 1.88 (1.30, 2.73)  
   No 7,818 (95.3) 87.81 (0.45) 12.19 (0.45) 1.00  
Financial hardship**     0.00 
Yes 293 (3.7) 65.10 (3.32) 34.90 (3.32) 4.00 (2.94, 5.45)  
   No 7853 (96.3) 88.18 (0.44) 11.82 (0.44) 1.00  
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Risk Factors (Biopsychosocial Conditions): 
Biopsychosocial conditions were measured to account for the behavioral and 
psychological responses relating to the overall health condition of those potentially 
screening for MDD. 
Those seniors whose biological mother [OR 4.69; 95% CI: (3.76, 5.84)] or father 
[OR 3.80; 95% CI: (2.83, 5.11)] were depressed were significantly more likely to suffer 
from MDD than those who reported their biological mother or father not being depressed 
as compared to the results within (Table 4.2). 
Those seniors who father was self-reported to have been an alcoholic [OR 3.04; 95% CI: 
(1.97, 4.71)] and those who reported their mother to have been an alcoholic [OR 1.86; 
95% CI: (1.50, 2.30)] were significantly more likely to screen positive for MDD. 
Those seniors who either had a close family member or friend die (last 12 months) 
or had a close family member or friend experience serious injury or illness (DSI/I) [Table 
4.2] were significantly more likely to suffer from MDD [OR 1.56; 95% CI: (1.28, 1.90)] 
than those who did not and, if they experienced “both”, they were also significantly more 
likely to suffer from MDD [OR 2.00; 95% CI: (1.64, 2.43)] than those who did not report 
an experience of any of the conditions above. 
Those seniors surveyed who were “not open” [OR 2.48; 95% CI: (1.98, 3.11)], did 
not ask for help when needed [OR 1.77; 95% CI: (1.46, 2.15)], and self-reported to be 
“stubborn” [OR 1.60; 95% CI: (1.35, 1.89)] were all significantly more likely to suffer 
from MDD than those who did not report the listed conditions above (Table 4.2).   
  
91
 
Table 4.2 Descriptive Characteristics and Risk Factors for Major Depression, persons 65 and older, 2001-2002 NESARC 
 Total 
n=8,205 
Frequency / % 
No Major 
Depression 
n=7,148 %(se) 
Major 
Depression 
n=1,057 %(se) 
OR for Major 
Depression 
OR (LCL, UCL) p-value 
Biopsychosocial 
conditions 
     
Mother depressed** 
    0.00 
Yes 654 (9.2) 65.87(2.08) 34.13 (2.08) 4.69 (3.76, 5.84)  
No 6,461 (90.8) 90.05 (0.47) 9.95 (0.47) 1.00  
Father depressed**     0.00 
   Yes 339 (5.0) 68.37 (3.11) 31.36 (3.11) 3.80 (2.83, 5.11)  
   No 6,454 (95.0) 89.15 (0.45) 10.85 (0.45) 1.00  
Father (Alcohol)**     0.00 
   Yes 147 (1.9) 70.16 (4.42) 29.84 (4.42) 3.04 (1.97, 4.71)  
   No 7,797 (98.1) 87.74 (0.46) 12.26 (0.46) 1.00  
Mother 
(Alcohol)** 
    0.00 
   Yes 866 (11.2) 80.43 (1.60) 19.57 (1.60) 1.86 (1.50, 2.30)  
   No 6,873 (88.8) 88.40 (0.46) 11.60 (0.46) 1.00  
DSI/I**     0.00 
   None 3,834 (47.3) 90.63 (0.55) 9.37 (0.55) 1.00 - 
   Either** 2,442 (30.2) 86.13 (0.78) 13.87 (0.78) 1.56 (1.28, 1.90) 0.00 
   Both** 1,818 (22.5) 82.88 (1.17) 17.12 (1.17) 2.00 (1.64, 2.43) 0.00 
Not Open**     0.00 
   Yes 639 (8.1) 75.39 (2.05) 24.61 (2.05) 2.48 (1.98, 3.11)  
   No 7,287 (91.9) 88.38 (0.44) 11.62 (0.44) 1.00  
Not Help**     0.00 
   Yes 1,202 (15.2) 81.23 (1.24) 18.77 (1.24) 1.77 (1.46, 2.15)  
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 Total 
n=8,205 
Frequency / % 
No Major 
Depression 
n=7,148 %(se) 
Major 
Depression 
n=1,057 %(se) 
OR for Major 
Depression 
OR (LCL, UCL) p-value 
   No 6,686 (84.8) 88.48 (0.50) 11.52 (0.50) 1.00  
Stubborn**     0.00 
   Yes 2,350 (29.7) 83.58 (0.91) 16.42 (0.91) 1.60 (1.35, 1.89)  
   No 5,558 (70.3) 89.05 (0.51) 10.95 (0.51) 1.00  
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Risk Factors (Medical Comorbidities): 
Medical comorbidities were added to the model to control for physiological factors 
associated with MDD or depression (P). 
Seniors within the survey who self-reported having pain “not at all” [OR 0.40; 95% 
CI: (0.30, 0.52)] or “a little bit” [OR 0.64; 95% CI: (0.48, 0.85)] were significantly less 
likely to experience MDD than those who reported having “extreme” amounts of pain 
(Table 4.3). 
Those persons reporting “hypertension (P/E)” [OR 1.33; 95% CI: (1.13, 1.56)], 
“chest pain (P/E) [OR 2.60; 95% CI: (2.10, 3.20)] and “rapid heartbeat” [OR 2.03; 95% 
CI: (1.63, 2.52)] were significantly more likely to experience MDD compared to those 
who did not report having each of these particular conditions (Table 4.3). 
Elderly persons who reported “other heart disease” [OR 1.75; 95% CI: (1.38, 2.21)] 
were significantly more likely to suffer from MDD than those who did not report having 
another heart disease (Table 4.3). 
Those older persons surveyed who had both an evaluated (E) alcohol abuse and 
dependency condition [OR 2.40; 95% CI: (1.70, 3.39)] were significantly more likely to 
suffer from MDD than those without an evaluated (E) alcoholic diagnosis (Table 4.3). 
Surveyed seniors who were evaluated (E) to have “nicotine dependence” [OR 2.47; 
95% CI: (1.95, 3.13)] were significantly more likely to experience MDD than those 
without an evaluated condition of “nicotine dependence” (Table 4.3). 
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Table 4.3 Descriptive Characteristics and Risk Factors for Major Depression, persons 65 and older, 2001-2002 NESARC 
 
 Total 
n=8,205 
Frequency / % 
No Major 
Depression 
n=7,148 %(se) 
Major 
Depression 
n=1,057 %(se) 
OR for Major 
Depression 
OR (LCL, UCL) p-value 
Medical 
comorbidities 
     
Pain      
   Not at all** 3,637 (44.7) 91.58 (0.50) 8.42 (0.50) 0.40 (0.30, 0.52) 0.00 
   A little bit** 1,658 (20.4) 87.19 (0.90) 12.81 (0.90) 0.64 (0.48, 0.85) 0.00 
   Moderately 1,069 (13.1) 85.65 (1.32) 14.35 (1.32) 0.73 (0.53, 1.00) 0.05 
   Quite a bit 1,107 (13.6) 79.16 (1.48) 20.84 (1.48) 1.14 (0.85, 1.54) 0.37 
   Extremely 664 (8.2) 81.28 (1.89) 18.72 (1.89) 1.00 - 
Hypertension 
(P/E)** 
     
   Yes 3,910 (47.7) 85.71 (0.72) 14.29 (0.72) 1.33 (1.13, 1.56) 0.00 
   No 4,295 (52.3) 88.83 (0.56) 11.17 (0.56) 1.00  
Chest Pain (P/E)**      
   Yes 1,018 (12.4) 75.77 (1.81) 24.23 (1.81) 2.60 (2.10, 3.20) 0.00 
   No 7,187 (87.6) 89.03 (0.44) 10.97 (0.44) 1.00  
Rapid Heart (P/E)** 
    0.00 
   Yes 925 (11.3) 79.09 (1.67) 20.91 (1.67) 2.03 (1.63, 2.52)  
   No 7,280 (88.7) 88.47 (0.46) 11.53 (0.46) 1.00  
Heart Attack (P/E)     0.15 
   Yes 265 (3.2) 83.75 (2.75) 16.25 (2.75) 1.35 (0.89, 2.06)  
   No 7,940 (96.8) 87.47 (0.47) 12.53 (0.47) 1.00  
Other Heart 
Disease (P/E)** 
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 Total 
n=8,205 
Frequency / % 
No Major 
Depression 
n=7,148 %(se) 
Major 
Depression 
n=1,057 %(se) 
OR for Major 
Depression 
OR (LCL, UCL) p-value 
   Yes 709 (8.6) 80.82 (1.70) 19.18 (1.70) 1.75 (1.38, 2.21) 0.00 
   No 7,496 (91.4) 88.05 (0.47) 11.95 (0.47) 1.00  
Alcohol 
Abuse/Depend (E)  
     
   No diagnosis 7,005 (85.4) 88.00 (0.47) 12.00 (0.47) 1.00 - 
   Abuse only 934 (11.4)  88.16 (1.26) 11.84 (1.26) 0.99 (0.76, 1.27) 0.90 
   Abuse/Depend** 227 (2.8) 75.31 (3.21) 24.69 (3.21) 2.40 (1.70, 3.39) 0.00 
Nicotine Depend 
(E)** 
    0.00 
   Yes 663 (8.1) 88.67 (0.44) 11.33 (0.44) 2.47 (1.95, 3.13)  
   No 7,542 (91.9) 76.00 (2.03) 24.00 (2.03) 1.00  
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Comparing MDD and Depression (P) 
 
It is important to reiterate the differences between the two dependent variables 
examined within the study: MDD and depression (P).  MDD was defined by the 
NESARC survey which utilized a series of questions to determine the dichotomous 
responses to those needed by the DSM-IV for a clinician to diagnose a patient with major 
depressive disorder.  Five of nine questions needed to be positive to positively account 
for MDD within the study.  Depression (P) was given a positive response if those seniors 
surveyed responded positively to the following question, “During the past four weeks, 
how often have you felt downhearted or depressed”?  A positive response required that 
the respondent answer either “all of the time” or “most of the time”. 
Among all older adults, 7.32% reported that that they had felt "downhearted or 
depressed" either all or most of the time during the past four weeks.  Self-reported 
depression was more common among persons who screened positive for MDD (20.40%) 
than among persons who did not (5.46%) [Table 4.4, below].  It is notable that most older 
adults who screened positive for depression (79.60%) did not actually self-report 
depression.  
Table 4.4. Overlap between MDD and Depression (P) among persons 65 and older, by 
reported Arthritis (P/E), NESARC 2001-2002.   
 
Variables Total (%) MDD No MDD Chi Squared P 
Value 
      
  Arthritis (P/E) Present (n=609; 7.42%) 
 
Depression (P)      
   Yes  519 (87.06) 429 (83.25) 90 (16.75) 17.94 .0001 
   No 90 (12.94) 48 (48.99) 42 (51.01)   
   Total  477 (78.82) 132 (21.18)   
Arthritis (P/E) Not Present (n=7,596; 92.58%) 
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Depression (P)      
   Yes  549 (6.87) 177 (32.18) 372 (67.82) 39.61 .0000 
   No 7,047 
(93.13) 
748 (10.22) 6,299 
(89.78) 
  
Total  925 (11.73) 6,671 
(88.27) 
  
 
Multivariate Model [MDD and Depression (P)] 
Model 1: MDD {DV} = logit[Arthritis (P/E) {IV of interest}]  
               Depression (P) {DV} = logit[Arthritis (P/E) {IV of interest}] 
 
Model 2: MDD {DV} = logit[Arthritis (P/E) {IV of interest} + Predisposing 
Characteristics + Enabling Characteristics]  
               Depression (P) {DV} = logit[Arthritis (P/E) {IV of interest} + 
Predisposing Characteristics + Enabling Characteristics] 
 
Model 3: MDD {DV} = logit[Arthritis (P/E) {IV of interest} + Predisposing 
Characteristics +  Enabling Characteristics + Biopsychosocial 
Conditions] 
               Depression (P) {DV} = logit[Arthritis (P/E) {IV of interest} + 
Predisposing Characteristics + Enabling Characteristics + 
Biopsychosocial Conditions] 
 
Model 4 : MDD {DV} = logit[Arthritis (P/E) {IV of interest} + Predisposing 
Characteristics +  Enabling Characteristics + Biopsychosocial 
Conditions + Medical Comorbidities] 
 
               Depression (P) {DV} = logit[Arthritis (P/E) {IV of interest} + 
Predisposing Characteristics + Enabling Characteristics + 
Biopsychosocial Conditions + Medical Comorbidities] 
 
Multivariate: Model 1 [MDD] 
Those elderly who experienced arthritis (P/E) [OR 2.00; 95% CI: (1.52, 2.65)] were 
significantly more likely to experience MDD than those who did not experience arthritis 
(P/E) [Table 4.4].   
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Multivariate: Model 2 [MDD] 
Compared to those who did not experience arthritis (P/E), those who experienced 
arthritis (P/E) [OR 1.87; 95% CI: (1.41, 2.47)] were significantly more likely to 
experience MDD [Table 4.4].   
Multivariate: Model 3 [MDD] 
Arthritis (P/E) was significantly associated with the likelihood of MDD [OR 1.87; 
95% CI: (1.31, 2.67)]. 
Multivariate: Model 4 [MDD] 
Those elderly who experienced arthritis (P/E) [OR 1.60; 95% CI: (1.12, 2.28)] were 
significantly more likely to experience MDD than those who did not experience arthritis 
(P/E) [Table 4.4].   
Multivariate: Model 1 [Depression (P)] 
Those seniors surveyed who experienced arthritis (P/E) [OR 2.02; 95% CI: (1.52, 
2.68)] were significantly more likely to experience depression (P) than those who did not 
experience arthritis (P/E) [Table 4.5]. 
Multivariate: Model 2 [Depression (P)] 
Those elderly who experienced arthritis (P/E) [OR 1.34; 95% CI: (0.98, 1.83)] were 
no more likely to experience depression (P) than those who did not experience arthritis 
(P/E) [Table 4.5].   
Multivariate: Model 3 [Depression (P)] 
Those persons suffering from arthritis (P/E) were no more likely [OR 1.40; 95% CI: 
(0.96, 2.04)] to report depression (P) than those without arthritis (P/E) [Table 4.5].   
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Multivariate: Model 4 [Depression (P)] 
Those persons suffering from arthritis (P/E) were no more likely [OR 1.33; 95% CI: 
(0.89, 1.99)] to suffer from depression (P) than those not suffering from arthritis (P/E) 
[Table 4.5].   
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4.3 MULTIVARIATE ANALYSIS [MDD] 
Table 4.5 Factors associated with MDD among population 65 years and older, NESARC 2001-2002.   
 
 
Table Variables 
 Model 1 
n=8,205 
N=33,764,930 
%(se) 
Model 2 
n=8,128 
N=33,505,384 
%(se) 
Model 3 
n=6,384 
N=26,718,861 
%(se) 
Model 4 
n=6,380 
N=26,709,788 
%(se) 
 
 
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Hypothesized IV      
Arthritis Yes 2.00 (1.52, 2.65)** 1.87 (1.41, 2.47)** 1.87 (1.31, 2.67)** 1.60 (1.12, 2.28)** 
 No 1.00 1.00 1.00 1.00 
Predisposing 
Characteristics 
     
Place of birth U.S. born  0.96 (0.71, 1.31) 0.79 (0.55, 1.13) 0.74 (0.51, 1.06) 
 Non-U.S. born  1.00 1.00 1.00 
Race Non-Hispanic 
White 
 1.00 1.00 1.00 
 Non-Hispanic 
Black 
 0.60 (0.46, 0.79)** 0.71 (0.49, 1.04) 0.72 (0.48, 1.07) 
 Hispanic  0.83 (0.58, 1.20) 0.92 (0.61, 1.40) 0.99 (0.66, 1.49) 
 Non-Hispanic 
other 
 1.06 (0.74, 1.53) 1.65 (1.10, 2.46) 1.72 (1.12, 2.64) 
Gender Male  1.00 1.00 1.00 
 Female  2.26 (1.86, 2.75)** 2.15 (1.72, 2.69)** 2.21 (1.74, 2.82)** 
Health status Excellent  1.00 1.00 1.00 
 Very good  0.96 (0.71, 1.29) 0.78 (0.56, 1.08) 0.70 (0.50, 0.98)** 
 Good  1.21 (0.90, 1.61) 1.03 (0.75, 1.40) 0.84 (0.60, 1.17) 
 Fair  1.65 (1.23, 2.20)** 1.31 (0.95, 1.81) 0.91 (0.64, 1.30) 
 Poor  2.44 (1.77, 3.38)** 2.02 (1.38, 2.97)** 1.27 (0.79, 2.05) 
Age 65-74  1.00 1.00 1.00 
 75-84  0.71 (0.59, 0.85)** 0.77 (0.62, 0.96)** 0.81 (0.65, 1.01) 
 85+  0.42 (0.32, 0.56)** 0.40 (0.27, 0.57)** 0.43 (0.29, 0.62)** 
Region Northeast  1.00 1.00 1.00 
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Table Variables 
 Model 1 
n=8,205 
N=33,764,930 
%(se) 
Model 2 
n=8,128 
N=33,505,384 
%(se) 
Model 3 
n=6,384 
N=26,718,861 
%(se) 
Model 4 
n=6,380 
N=26,709,788 
%(se) 
 Midwest  1.19 (0.92, 1.53) 1.05 (0.79, 1.40) 0.99 (0.74, 1.32) 
 South  1.12 (0.89, 1.41) 1.12 (0.86, 1.46) 1.07 (0.81, 1.41) 
 West  1.29 (1.01, 1.65)** 1.17 (0.87, 1.56) 1.09 (0.81, 1.47) 
Enabling 
Characteristics 
  
   
Education Some high 
school/less 
 0.90 (0.69, 1.19) 0.89 (0.65, 1.21) 0.86 (0.63, 1.18) 
 Complete high 
school 
 0.94 (0.75, 1.18) 0.96 (0.72, 1.27) 0.95 (0.72, 1.26) 
 Some college  0.94 (0.70, 1.25) 0.95 (0.69, 1.32) 0.94 (0.67, 1.32) 
 College 
graduate 
 1.00 1.00 1.00 
Medicare Yes  1.24 (0.83, 1.84) 1.13 (0.72, 1.78) 1.11 (0.70, 1.74) 
 No  1.00 1.00 1.00 
Medicaid Yes  0.92 (0.66, 1.27) 0.84 (0.58, 1.22) 0.83 (0.57, 1.21) 
 No  1.00 1.00 1.00 
Private Insurance Yes  1.17 (0.98, 1.40) 1.02 (0.82, 1.26) 1.02 (0.83, 1.26) 
 No  1.00 1.00 1.00 
Income level $0-$10,000  0.83 (0.62, 1.10) 0.86 (0.61, 1.23) 0.89 (0.63, 1.25) 
 $10,001-
$20,000  
 0.98 (0.76, 1.25) 1.04 (0.77, 1.40) 1.03 (0.76, 1.40) 
 $20,001-
$30,000 
 0.85 (0.65, 1.11) 0.88 (0.63, 1.25) 0.89 (0.63, 1.25) 
 $30,001-
$40,000 
 0.82 (0.62, 1.10) 0.83 (0.59, 1.17) 0.84 (0.60, 1.20) 
 $40,001-higher  1.00 1.00 1.00 
SSI income Yes  1.13 (0.79, 1.61) 1.15 (0.76, 1.76) 1.14 (0.75, 1.72) 
 No  1.00 1.00 1.00 
Food stamps Yes  1.48 (0.96, 2.30) 1.23 (0.72, 2.12) 1.08 (0.63, 1.86) 
 No  1.00 1.00 1.00 
Financial hardship Yes  3.82 (2.74, 5.33)** 3.33 (2.19, 5.06)** 2.99 (1.95, 4.56)** 
 No  1.00 1.00 1.00 
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Table Variables 
 Model 1 
n=8,205 
N=33,764,930 
%(se) 
Model 2 
n=8,128 
N=33,505,384 
%(se) 
Model 3 
n=6,384 
N=26,718,861 
%(se) 
Model 4 
n=6,380 
N=26,709,788 
%(se) 
Biopsychosocial 
conditions 
     
Mother (Depressed) Yes   3.47 (2.56, 4.69)** 3.33 (2.44, 4.55)** 
 No   1.00 1.00 
Father (Depressed) Yes   1.79 (1.21, 2.65)** 1.74 (1.16, 2.62)** 
 No   1.00 1.00 
Father (Alcohol) Yes   1.46 (0.72, 2.94) 1.35 (0.66, 2.76) 
 No   1.00 1.00 
Mother (Alcohol) Yes   1.41 (1.07, 1.87)** 1.34 (1.00, 1.80) 
 No   1.00 1.00 
DSI/I None   0.66 (0.51, 0.85)** 0.69 (0.54, 0.89)** 
 Either   1.00  1.00 
 Both   1.22 (0.95, 1.58) 1.23 (0.95, 1.59) 
Not open Yes   1.65 (1.22, 2.23)** 1.60 (1.18, 2.16)** 
 No   1.00 1.00 
Not help Yes   1.33 (1.02, 1.72)** 1.25 (0.95, 1.64) 
 No   1.00 1.00 
Stubborn Yes   1.34 (1.08, 1.66)** 1.27 (1.03, 1.58)** 
 No   1.00 1.00 
Medical 
comorbidities 
   
  
Pain Not at all    0.69 (0.46, 1.05) 
 A little bit    0.90 (0.60, 1.36) 
 Moderately    0.92 (0.58, 1.47) 
 Quite a bit    1.26 (0.82, 1.93) 
 Extremely    1.00 
Hypertension (P/E) Yes    1.04 (0.85, 1.27) 
 No    1.00 
Chest pain (P/E) Yes     1.63 (1.22, 2.16)** 
 No    1.00 
Rapid heart (P/E) Yes    1.14 (0.85, 1.53) 
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Table 3 (Variable) 
 Model 1 
n=8,205 
N=33,764,930 
%(se) 
Model 2 
n=8,128 
N=33,505,384 
%(se) 
Model 3 
n=6,384 
N=26,718,861 
%(se) 
Model 4 
n=6,380 
N=26,709,788 
%(se) 
 No    1.00 
Heart attack (P/E) Yes     0.68 (0.35, 1.32) 
 No    1.00 
Other heart disease 
(P/E) 
Yes    0.94 (0.69, 1.28) 
 No    1.00 
Alcohol 
Abuse/Depend (E) 
No alcohol    1.00 
 Abuse only    1.12 (0.79, 1.60) 
 Abuse and 
depend 
   1.46 (0.83, 2.55) 
Nicotine Depend (E) Yes    1.82 (1.31, 2.51)** 
 No    1.00 
** represents all significant variables with a p-value less than or equal to 0.05
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Table 4.6 Factors associated with perceived depression among population 65 years and older, NESARC 2001-2002.   
 
 
Table Variables 
 Model 1 
n=8,205 
N=33,764,930 
%(se) 
Model 2 
n=8,128 
N=33,505,384 
%(se) 
Model 3 
n=6,384 
N=26,718,861 
%(se) 
Model 4 
n=6,380 
N=26,709,788 
%(se) 
 
 
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Hypothesized IV      
Arthritis Yes 2.02 (1.52, 2.68)** 1.34 (0.98, 1.83) 1.40 (0.96, 2.04) 1.33 (0.89, 1.99) 
 No 1.00 1.00 1.00 1.00 
Predisposing 
Characteristics 
     
Place of birth U.S. born  0.67 (0.45, 0.99)** 0.60 (0.38, 0.95)** 0.58 (0.37, 0.91)** 
 
Non-U.S. born 
 1.00 1.00 1.00 
Race Non-Hispanic 
White 
 1.00 1.00 1.00 
 Non-Hispanic 
Black 
 0.76 (0.57, 1.02) 0.79 (0.53, 1.17) 0.81 (0.54, 1.22) 
 Hispanic  0.82, 0.55, 1.22) 0.93 (0.58, 1.48) 0.96 (0.60, 1.54) 
 Non-Hispanic 
other 
 0.95 (0.49, 1.85) 1.11 (0.56, 2.20) 1.15 (0.58, 2.30) 
Gender Male  1.00 1.00 1.00 
 Female  1.30 (1.05, 1.61)** 1.25 (0.99, 1.58) 1.22 (0.95, 1.57) 
Health status Excellent  1.00 1.00 1.00 
 Very good  1.23 (0.69, 2.18) 1.22 (0.62, 2.37) 1.09 (0.56, 2.12) 
 Good  1.67 (0.96, 2.90) 1.64 (0.87, 3.11) 1.35 (0.70, 2.58) 
 Fair  3.00 (1.73, 5.21)** 2.64 (1.42, 4.92)** 1.71 (0.90, 3.24) 
 Poor  8.92 (5.13, 15.51)** 8.12 (4.20, 15.71)** 4.08 (1.99, 8.36)** 
Age 65-74  1.00 1.00 1.00 
 75-84  0.93 (0.73, 1.19) 0.93 (0.70, 1.23) 0.92 (0.70, 1.22) 
 85+  0.90 (0.64, 1.26) 0.99 (0.66, 1.48) 1.07 (0.71, 1.60) 
Region Northeast  1.00 1.00 1.00 
 Midwest  0.90 (0.66, 1.22) 0.84 (0.58, 1.22) 0.80 (0.55, 1.14) 
 South  1.04 (0.78, 1.37) 0.94 (0.66, 1.36) 0.89 (0.63, 1.27) 
 West  0.87 (0.60, 1.25) 0.82 (0.53, 1.26) 0.77 (0.51, 1.18) 
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Table 3 (Variable) 
 Model 1 
n=8,205 
N=33,764,930 
%(se) 
Model 2 
n=8,128 
N=33,505,384 
%(se) 
Model 3 
n=6,384 
N=26,718,861 
%(se) 
Model 4 
n=6,380 
N=26,709,788 
%(se) 
Enabling 
Characteristics 
  
   
Education Some high 
school/less 
 1.65 (1.13, 2.42)** 1.63 (1.04, 
2.57)** 
1.57 (0.99, 2.48) 
 Complete high 
school 
 1.29 (0.90, 1.86) 1.30 (0.86, 1.97) 1.29 (0.85, 1.95) 
 Some college  0.89 (0.57, 1.39) 0.87 (0.54, 1.41) 0.86 (0.53, 1.42) 
 College graduate  1.00 1.00 1.00 
Medicare Yes  1.39 (0.87, 2.21) 1.42 (0.78, 2.60) 1.43 (0.80, 2.55) 
 No  1.00 1.00 1.00 
Medicaid Yes  1.11 (0.80, 1.55) 0.99 (0.65, 1.51) 0.97 (0.63, 1.49) 
 No  1.00 1.00 1.00 
Private Insurance Yes  0.72 (0.57, 0.92)** 0.69 (0.52, 0.90) 0.71 (0.54, 0.93) 
 No  1.00 1.00 1.00 
Income level $0-$10,000  0.89 (0.57, 1.38) 1.20 (0.72, 1.99) 1.23 (0.75, 2.02) 
 $10,001-$20,000  1.13 (0.76, 1.68) 1.37 (0.88, 2.15) 1.39 (0.89, 2.17) 
 $20,001-$30,000  0.95 (0.63, 1.44) 1.21 (0.75, 1.95) 1.28 (0.80, 2.06) 
 $30,001-$40,000  0.97 (0.60, 1.55) 1.30 (0.76, 2.24) 1.33 (0.77, 2.31) 
 $40,001-higher  1.00 1.00 1.00 
SSI income Yes  1.25 (0.85, 1.82) 1.29 (0.81, 2.06) 1.36 (0.86, 2.17) 
 No  1.00 1.00 1.00 
Food stamps Yes  1.18 (0.70, 1.99) 1.14 (0.57, 2.32) 1.02 (0.52, 2.03) 
 No  1.00 1.00 1.00 
Financial hardship Yes  3.24 (2.20, 4.77) 3.39 (2.17, 
5.31)** 
2.98 (1.90, 4.68)** 
 No  1.00 1.00 1.00 
Biopsychosocial 
conditions 
     
Mother (Depressed) Yes   1.14 (0.72, 1.80) 1.11 (0.68, 1.79) 
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Table 3 (Variable) 
 Model 1 
n=8,205 
N=33,764,930 
%(se) 
Model 2 
n=8,128 
N=33,505,384 
%(se) 
Model 3 
n=6,384 
N=26,718,861 
%(se) 
Model 4 
n=6,380 
N=26,709,788 
%(se) 
 No   1.00 1.00 
Father (Depressed) Yes   1.74 (0.97, 3.12) 1.72 (0.93, 3.18) 
 No   1.00 1.00 
Father (Alcohol) Yes   1.77 (0.82, 3.80) 1.66 (0.77, 3.58) 
 No   1.00 1.00 
Mother (Alcohol) Yes   1.12 (0.78, 1.60) 1.10 (0.76, 1.60) 
 No   1.00 1.00 
DSI/I None   0.98 (0.74, 1.29) 1.06 (0.79, 1.42) 
 Either   1.00 1.00 
 Both   1.31 (0.94, 1.82) 1.34 (0.95, 1.89) 
Not open Yes   1.37 (0.93, 2.03) 1.35 (0.90, 2.02) 
 No   1.00 1.00 
Not help Yes   1.18 (0.82, 1.70) 1.10 (0.76, 1.61) 
 No   1.00 1.00 
Stubborn Yes   1.16 (0.88, 1.52) 1.09 (0.83, 1.44) 
 No   1.00 1.00 
Medical 
comorbidities 
   
  
Pain Not at all    0.25 (0.17, 0.37)** 
 A little bit    0.36 (0.24, 0.55)** 
 Moderately    0.38 (0.24, 0.62)** 
 Quite a bit    0.65 (0.45, 0.95)** 
 Extremely    1.00 
Hypertension (P/E) Yes    1.07 (0.81, 1.42) 
 No    1.00 
Chest pain (P/E) Yes     1.05 (0.73, 1.52) 
 No    1.00 
Rapid heart (P/E) Yes    1.30 (0.92, 1.83) 
 No    1.00 
Heart attack (P/E) Yes    0.93 (0.54, 1.60) 
 No    1.00 
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Table 3 (Variable) 
 Model 1 
n=8,205 
N=33,764,930 
%(se) 
Model 2 
n=8,128 
N=33,505,384 
%(se) 
Model 3 
n=6,384 
N=26,718,861 
%(se) 
Model 4 
n=6,380 
N=26,709,788 
%(se) 
Other heart disease 
(P/E) 
Yes    0.73 (0.50, 1.08) 
 No    1.00 
Alcohol 
Abuse/Depend (E) 
No alcohol    1.00 
 Abuse only    1.33 (0.89, 1.99) 
 Abuse and 
depend 
   1.27 (0.56, 2.90) 
Nicotine Depend (E) Yes    1.12 (0.70, 1.80) 
 No    1.00 
 
** represents all significant variables with a p-value less than or equal to 0.05
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CHAPTER FIVE: DISCUSSION 
5.1 BACKGROUND 
The purpose of this study was to explore both positive screened MDD and the 
perception of being depressed (P) and the likelihood of either increasing if the patient 
suffered from arthritis (P/E), either perceived or evaluated by a physician.  The study 
explored the univariate, bivariate, and multivariate relationships between MDD and 
depression (P) to better describe influencing characteristics and their prevalence, as 
related to MDD and depression (P). 
5.2 SUMMARY 
It is important to reiterate the differences between the two dependent variables 
examined within the study: MDD and depression (P).  MDD was a positive screening 
variable that was developed from the NESARC survey which utilized a series of 
questions to determine the dichotomous responses to those needed by the DSM-IV for a 
clinician to diagnose a patient with major depressive disorder.  Five of nine questions 
needed to be positive to positively account for MDD within the study.  Depression (P) 
was given a positive response if those seniors surveyed responded positively to the 
following question, “During the past four weeks, how often have you felt downhearted or 
depressed”?  A positive response required that the respondent answer either “all of the 
time” or “most of the time”. 
Among all older adults, 7.32% reported that that they had felt "downhearted or 
depressed" either all or most of the time during the past four weeks.  Self-reported 
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depression was more common among persons who screened positive for MDD (20.40%) 
than among persons who did not (5.46%).  It is notable that most older adults who 
screened positive for depression (79.60%) did not actually self-report depression.  
The following were the hypotheses projected and comments regarding their overall 
outcomes with the study: 
H1: Those persons age 65 and older who report having arthritis (P/E) will be significantly 
more likely to be suffering from MDD than those who have not reported having an 
arthritic condition (P/E) [results were positive within Models 2-4]. 
H2: Those persons age 65 and older who report having arthritis (P/E) will be significantly 
more likely to be suffering from depression (P) than those who have not reported having 
an arthritic condition (P/E) [results were negative within Models 2-4].  
This creates significant concern, given that each of the multivariate models (2-4) 
examined arthritis (P/E) while utilizing the same control variables throughout.   Further, 
many of the relationally significant variables in the MDD versus depression (P) models 
were not the same (Table 4.4 /4.5). 
5.3 LIMITATIONS OF THE STUDY 
There were several limitations to the study which need to be addressed.  NESARC 
was surveyed from 2001-02 so the outcome data are beginning to become dated.  The 
depression (P) variable was recoded to include a dichotomous variable included the 
following two response options: (1) all of the time/most of the time (2) all other 
responses.  This was done to utilize multiple logistic regression to analyze Models 1-3 in 
the multivariate model.  Some of the selection variables were somewhat limited in 
response size, given that their subcategories were greater than three.  Lastly, the study 
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was originally intended to be an alcohol and drug survey collection tool so the overall 
sample population selection and survey questioning and administration could not be 
reviewed for quality. 
5.4 CONCLUSIONS 
Those seniors who suffer from arthritis (P/E) were more likely to also suffer from 
MDD in all models tested.  However, those same seniors were not more likely to suffer 
from arthritis (P/E) in all models (2-4) when analyzing depression (P).  Further, the 
bivariate relationship between MDD and the control variables conclusively expressed 
differing results within the multivariate analysis than did those expressed between 
depression (P) and arthritis.  This study examined arthritis (P/E) and their comparable 
relationship to whether the senior suffered from either MDD or depression (P).  The 
results demonstrated conclusive evidence that one cannot count on an elderly patient to 
have a positive perception of depression as it relates to being positively screened for 
MDD.  Further, it would appear that older persons may not disclose whether or not they 
are depressed in a clinical environment.  This becomes important to clinicians and further 
demonstrated the need for clinically valid assessment measures to ensure preventative 
measures are being taken to address elderly depression. 
5.5 RECOMMENDATIONS 
The variations between the multivariate models (2-4) outcomes and the two 
dependent variables [MDD and depression (P)] suggest further investigation into dependent 
variable differences is needed.  Primarily, a cross sectional review outlining the 
differences between MDD and depression (P) and those variables in which stratification 
could provide some account for demonstrated differences throughout this study.  
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Gender needs to be further investigated, given its significance in Models 2-4 (all 
multivariate models) when modeled with MDD.  Further, gender was not significant in 
any of the depression (P) multivariate models.  In Model 4, women were significantly 
more likely to suffer from MDD than men [OR 2.21; 95% CI: (1.74, 2.82)], however, no 
significance was reported in Model 4 when control variables examined with depression 
(P) [OR 1.22; 95% CI: (0.95, 1.57)].  The differences between gender and depression for 
those 65 years old and greater would add clinical value for those practitioners attempting 
to better understand gerontology and mental health treatment.   
The biological relationship between those with MDD and having reported their 
mother being depressed needs further study.  In Model 4, those who reported their 
biological mother being depressed were significantly more likely to suffer from MDD 
[OR 3.33; 95% CI: (2.44, 4.55)].  Conversely, in the depression (P) Model 4, someone 
reporting that their biological mother was depressed were no more likely to perceive 
themselves as depressed [OR 1.11; 95% CI: (0.68, 1.79)].  
Those experiencing financial hardship were significantly more likely to suffer from 
MDD and to perceive themselves as being depressed.  This was significant in all 
multivariate models when either MDD or depression (P) was the dependent variable 
being examined.   
Another area of future study would be the oldest old (85+) ability to be significantly 
less likely to be suffering from MDD than the youngest old (65-74) [OR 0.43; 95% CI: 
(0.29, 0.62).  This perhaps could lead to the development of coping mechanism 
techniques in which the oldest old demonstrate or disclose learned behaviors for dealing 
with medical issues and the aging process. 
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The final area of recommendation for further study would be concerning a patient’s 
perception with regards to pain and its impact on those who have arthritis.  In the MDD 
study, those who reported pain (all levels) were no more likely to suffer from MDD.  
However, those who reported pain (all levels) were significantly more likely to self-
report being depressed.   
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